WO2010133962A1 - Methods for analyzing agricultural and environmental samples using microfluidic systems - Google Patents
Methods for analyzing agricultural and environmental samples using microfluidic systems Download PDFInfo
- Publication number
- WO2010133962A1 WO2010133962A1 PCT/IB2010/001233 IB2010001233W WO2010133962A1 WO 2010133962 A1 WO2010133962 A1 WO 2010133962A1 IB 2010001233 W IB2010001233 W IB 2010001233W WO 2010133962 A1 WO2010133962 A1 WO 2010133962A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- sample
- seed
- fluid
- agricultural
- gene
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 100
- 230000007613 environmental effect Effects 0.000 title claims abstract description 19
- 239000007788 liquid Substances 0.000 claims abstract description 83
- 239000012530 fluid Substances 0.000 claims abstract description 78
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 52
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 22
- 238000002156 mixing Methods 0.000 claims abstract description 13
- 239000000523 sample Substances 0.000 claims description 115
- 239000000203 mixture Substances 0.000 claims description 17
- 239000003124 biologic agent Substances 0.000 claims description 15
- 239000003550 marker Substances 0.000 claims description 15
- 230000002068 genetic effect Effects 0.000 claims description 13
- 108020004707 nucleic acids Proteins 0.000 claims description 12
- 102000039446 nucleic acids Human genes 0.000 claims description 12
- 150000007523 nucleic acids Chemical class 0.000 claims description 12
- 102000004169 proteins and genes Human genes 0.000 claims description 9
- 235000014633 carbohydrates Nutrition 0.000 claims description 7
- 150000001720 carbohydrates Chemical class 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 7
- 238000007790 scraping Methods 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
- 239000000835 fiber Substances 0.000 claims description 6
- 241000894006 Bacteria Species 0.000 claims description 5
- 241000233866 Fungi Species 0.000 claims description 4
- 229920002472 Starch Polymers 0.000 claims description 4
- 239000013566 allergen Substances 0.000 claims description 4
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 4
- 239000000194 fatty acid Substances 0.000 claims description 4
- 229930195729 fatty acid Natural products 0.000 claims description 4
- 150000004665 fatty acids Chemical class 0.000 claims description 4
- 239000002207 metabolite Substances 0.000 claims description 4
- 235000019698 starch Nutrition 0.000 claims description 4
- 239000008107 starch Substances 0.000 claims description 4
- 150000001413 amino acids Chemical class 0.000 claims description 3
- 239000012491 analyte Substances 0.000 claims description 3
- 229930002875 chlorophyll Natural products 0.000 claims description 3
- 235000019804 chlorophyll Nutrition 0.000 claims description 3
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 claims description 3
- 230000002538 fungal effect Effects 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 239000003053 toxin Substances 0.000 claims description 3
- 231100000765 toxin Toxicity 0.000 claims description 3
- 239000002689 soil Substances 0.000 claims description 2
- 108020003215 DNA Probes Proteins 0.000 claims 3
- 239000003298 DNA probe Substances 0.000 claims 3
- 108020004518 RNA Probes Proteins 0.000 claims 3
- 239000003391 RNA probe Substances 0.000 claims 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims 1
- 230000002363 herbicidal effect Effects 0.000 claims 1
- 239000004009 herbicide Substances 0.000 claims 1
- 241000196324 Embryophyta Species 0.000 description 27
- 108020004414 DNA Proteins 0.000 description 19
- 238000004458 analytical method Methods 0.000 description 16
- 239000013615 primer Substances 0.000 description 16
- 229920002545 silicone oil Polymers 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 12
- -1 etc. Substances 0.000 description 12
- 238000012216 screening Methods 0.000 description 11
- 239000010408 film Substances 0.000 description 10
- 239000003795 chemical substances by application Substances 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- 230000003321 amplification Effects 0.000 description 8
- 238000003199 nucleic acid amplification method Methods 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 7
- 230000001488 breeding effect Effects 0.000 description 6
- 235000013339 cereals Nutrition 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000000427 antigen Substances 0.000 description 5
- 108091007433 antigens Proteins 0.000 description 5
- 102000036639 antigens Human genes 0.000 description 5
- 238000009395 breeding Methods 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 210000000349 chromosome Anatomy 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- 108091034117 Oligonucleotide Proteins 0.000 description 4
- 108700019146 Transgenes Proteins 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 239000000090 biomarker Substances 0.000 description 4
- 230000000295 complement effect Effects 0.000 description 4
- 238000011109 contamination Methods 0.000 description 4
- 238000007847 digital PCR Methods 0.000 description 4
- 239000000975 dye Substances 0.000 description 4
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 4
- 238000011065 in-situ storage Methods 0.000 description 4
- 108091033319 polynucleotide Proteins 0.000 description 4
- 102000040430 polynucleotide Human genes 0.000 description 4
- 239000002157 polynucleotide Substances 0.000 description 4
- 230000001681 protective effect Effects 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 238000009736 wetting Methods 0.000 description 4
- 108700028369 Alleles Proteins 0.000 description 3
- 102000053602 DNA Human genes 0.000 description 3
- 208000035240 Disease Resistance Diseases 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000000295 emission spectrum Methods 0.000 description 3
- 230000005284 excitation Effects 0.000 description 3
- 238000000695 excitation spectrum Methods 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 239000005350 fused silica glass Substances 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 239000000376 reactant Substances 0.000 description 3
- 230000000306 recurrent effect Effects 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 2
- 235000007319 Avena orientalis Nutrition 0.000 description 2
- 244000075850 Avena orientalis Species 0.000 description 2
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 2
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 238000007400 DNA extraction Methods 0.000 description 2
- 239000003155 DNA primer Substances 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 239000004812 Fluorinated ethylene propylene Substances 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- 240000004658 Medicago sativa Species 0.000 description 2
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 2
- 244000061176 Nicotiana tabacum Species 0.000 description 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 239000004696 Poly ether ether ketone Substances 0.000 description 2
- 238000001190 Q-PCR Methods 0.000 description 2
- 235000007238 Secale cereale Nutrition 0.000 description 2
- 240000003829 Sorghum propinquum Species 0.000 description 2
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 2
- 235000021536 Sugar beet Nutrition 0.000 description 2
- 108010006785 Taq Polymerase Proteins 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- 241000607479 Yersinia pestis Species 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 102000054766 genetic haplotypes Human genes 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- 210000001161 mammalian embryo Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000007899 nucleic acid hybridization Methods 0.000 description 2
- 235000018343 nutrient deficiency Nutrition 0.000 description 2
- 229920009441 perflouroethylene propylene Polymers 0.000 description 2
- 230000000737 periodic effect Effects 0.000 description 2
- 229920002530 polyetherether ketone Polymers 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000005086 pumping Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 230000011218 segmentation Effects 0.000 description 2
- 238000004557 single molecule detection Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- CZWUESRDTYLNDE-UHFFFAOYSA-N (2z)-2-[(2e,4e,6e)-7-[1-(5-carboxypentyl)-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]hepta-2,4,6-trienylidene]-1-ethyl-3,3-dimethylindole-5-sulfonate Chemical compound CC1(C)C2=CC(S([O-])(=O)=O)=CC=C2N(CC)\C1=C/C=C/C=C/C=C/C1=[N+](CCCCCC(O)=O)C2=CC=C(S(O)(=O)=O)C=C2C1(C)C CZWUESRDTYLNDE-UHFFFAOYSA-N 0.000 description 1
- OTLLEIBWKHEHGU-UHFFFAOYSA-N 2-[5-[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxy-4-phosphonooxyhexanedioic acid Chemical compound C1=NC=2C(N)=NC=NC=2N1C(C(C1O)O)OC1COC1C(CO)OC(OC(C(O)C(OP(O)(O)=O)C(O)C(O)=O)C(O)=O)C(O)C1O OTLLEIBWKHEHGU-UHFFFAOYSA-N 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- 108091093088 Amplicon Proteins 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 241000219195 Arabidopsis thaliana Species 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- 240000008100 Brassica rapa Species 0.000 description 1
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 1
- 244000188595 Brassica sinapistrum Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 241000193163 Clostridioides difficile Species 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 229920001651 Cyanoacrylate Polymers 0.000 description 1
- XPDXVDYUQZHFPV-UHFFFAOYSA-N Dansyl Chloride Chemical compound C1=CC=C2C(N(C)C)=CC=CC2=C1S(Cl)(=O)=O XPDXVDYUQZHFPV-UHFFFAOYSA-N 0.000 description 1
- 235000014466 Douglas bleu Nutrition 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 244000166124 Eucalyptus globulus Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 241000219146 Gossypium Species 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 241000208682 Liquidambar Species 0.000 description 1
- 235000006552 Liquidambar styraciflua Nutrition 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 238000009004 PCR Kit Methods 0.000 description 1
- 239000012807 PCR reagent Substances 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 229920001774 Perfluoroether Polymers 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- IAJOBQBIJHVGMQ-UHFFFAOYSA-N Phosphinothricin Natural products CP(O)(=O)CCC(N)C(O)=O IAJOBQBIJHVGMQ-UHFFFAOYSA-N 0.000 description 1
- 108010004729 Phycoerythrin Proteins 0.000 description 1
- 241000218657 Picea Species 0.000 description 1
- 235000005018 Pinus echinata Nutrition 0.000 description 1
- 241001236219 Pinus echinata Species 0.000 description 1
- 235000017339 Pinus palustris Nutrition 0.000 description 1
- 235000008577 Pinus radiata Nutrition 0.000 description 1
- 241000218621 Pinus radiata Species 0.000 description 1
- 235000008566 Pinus taeda Nutrition 0.000 description 1
- 241000218679 Pinus taeda Species 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 240000003889 Piper guineense Species 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 208000020584 Polyploidy Diseases 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 241000353135 Psenopsis anomala Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 240000001416 Pseudotsuga menziesii Species 0.000 description 1
- 235000005386 Pseudotsuga menziesii var menziesii Nutrition 0.000 description 1
- 240000000528 Ricinus communis Species 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 241000209056 Secale Species 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 208000035199 Tetraploidy Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 241000219793 Trifolium Species 0.000 description 1
- 208000026487 Triploidy Diseases 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000003322 aneuploid effect Effects 0.000 description 1
- 208000036878 aneuploidy Diseases 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000009833 antibody interaction Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000012062 aqueous buffer Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- JUPQTSLXMOCDHR-UHFFFAOYSA-N benzene-1,4-diol;bis(4-fluorophenyl)methanone Chemical compound OC1=CC=C(O)C=C1.C1=CC(F)=CC=C1C(=O)C1=CC=C(F)C=C1 JUPQTSLXMOCDHR-UHFFFAOYSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000012297 crystallization seed Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 238000012938 design process Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000013024 dilution buffer Substances 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 238000003708 edge detection Methods 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- HQQADJVZYDDRJT-UHFFFAOYSA-N ethene;prop-1-ene Chemical group C=C.CC=C HQQADJVZYDDRJT-UHFFFAOYSA-N 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 231100000776 exotoxin Toxicity 0.000 description 1
- 239000002095 exotoxin Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 235000004426 flaxseed Nutrition 0.000 description 1
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 238000010448 genetic screening Methods 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 210000003783 haploid cell Anatomy 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 238000009399 inbreeding Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000001823 molecular biology technique Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- ZTLGJPIZUOVDMT-UHFFFAOYSA-N n,n-dichlorotriazin-4-amine Chemical compound ClN(Cl)C1=CC=NN=N1 ZTLGJPIZUOVDMT-UHFFFAOYSA-N 0.000 description 1
- 239000002853 nucleic acid probe Substances 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 150000004713 phosphodiesters Chemical class 0.000 description 1
- 238000003976 plant breeding Methods 0.000 description 1
- 230000008121 plant development Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000002987 primer (paints) Substances 0.000 description 1
- 239000011253 protective coating Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000000275 quality assurance Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 238000007423 screening assay Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000009394 selective breeding Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000020238 sunflower seed Nutrition 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/38—Diluting, dispersing or mixing samples
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F33/00—Other mixers; Mixing plants; Combinations of mixers
- B01F33/30—Micromixers
- B01F33/302—Micromixers the materials to be mixed flowing in the form of droplets
- B01F33/3021—Micromixers the materials to be mixed flowing in the form of droplets the components to be mixed being combined in a single independent droplet, e.g. these droplets being divided by a non-miscible fluid or consisting of independent droplets
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F35/00—Accessories for mixers; Auxiliary operations or auxiliary devices; Parts or details of general application
- B01F35/71—Feed mechanisms
- B01F35/712—Feed mechanisms for feeding fluids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F35/00—Accessories for mixers; Auxiliary operations or auxiliary devices; Parts or details of general application
- B01F35/71—Feed mechanisms
- B01F35/717—Feed mechanisms characterised by the means for feeding the components to the mixer
- B01F35/7172—Feed mechanisms characterised by the means for feeding the components to the mixer using capillary forces
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F35/00—Accessories for mixers; Auxiliary operations or auxiliary devices; Parts or details of general application
- B01F35/71—Feed mechanisms
- B01F35/717—Feed mechanisms characterised by the means for feeding the components to the mixer
- B01F35/71805—Feed mechanisms characterised by the means for feeding the components to the mixer using valves, gates, orifices or openings
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F35/00—Accessories for mixers; Auxiliary operations or auxiliary devices; Parts or details of general application
- B01F35/75—Discharge mechanisms
- B01F35/754—Discharge mechanisms characterised by the means for discharging the components from the mixer
- B01F35/7547—Discharge mechanisms characterised by the means for discharging the components from the mixer using valves, gates, orifices or openings
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502769—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by multiphase flow arrangements
- B01L3/502784—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by multiphase flow arrangements specially adapted for droplet or plug flow, e.g. digital microfluidics
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/508—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
- B01L3/5088—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above confining liquids at a location by surface tension, e.g. virtual wells on plates, wires
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/10—Integrating sample preparation and analysis in single entity, e.g. lab-on-a-chip concept
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0809—Geometry, shape and general structure rectangular shaped
- B01L2300/0816—Cards, e.g. flat sample carriers usually with flow in two horizontal directions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
- B01L2300/0864—Configuration of multiple channels and/or chambers in a single devices comprising only one inlet and multiple receiving wells, e.g. for separation, splitting
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/16—Surface properties and coatings
- B01L2300/161—Control and use of surface tension forces, e.g. hydrophobic, hydrophilic
- B01L2300/165—Specific details about hydrophobic, oleophobic surfaces
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N2035/00178—Special arrangements of analysers
- G01N2035/00237—Handling microquantities of analyte, e.g. microvalves, capillary networks
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/11—Automated chemical analysis
- Y10T436/117497—Automated chemical analysis with a continuously flowing sample or carrier stream
- Y10T436/118339—Automated chemical analysis with a continuously flowing sample or carrier stream with formation of a segmented stream
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/17—Nitrogen containing
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/20—Oxygen containing
- Y10T436/203332—Hydroxyl containing
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/2575—Volumetric liquid transfer
Definitions
- the present invention generally relates to methods for analyzing agricultural and/or environmental samples using liquid bridges.
- breeding or genetic manipulation are used to make genetic improvements in plants. After a desirable improvement is achieved, commercial quantities are produced by planting and harvesting seeds over several generations. Breeding for enhanced agricultural products involves analysis of a large number of samples from plants to identify those plants with the desired properties for use or advancement to the next generation. For example, analysis of bulk seed batches for certain traits, such as high oil content or protein content, on a single plant or ear, in conjunction with an appropriate breeding methodology such as recurrent selection, often allows for the selection and introduction of such traits into a commercial population. Although the analysis of these seed batches can be performed by various techniques, methods that are rapid and low cost are most desirable.
- the present invention provides methods and devices for improved agricultural analysis and selective plant breeding.
- the invention involves using liquid bridges to analyze agricultural and/or environmental samples.
- Liquid bridges are used to produce sample droplets that contain reaction components for rapid analysis of small sample volumes.
- Liquid bridges allow the formation of sample droplets by through the interaction of immiscible fluids.
- liquid bridges are used for high throughput analysis of single seeds, allowing for the analysis and identification of agricultural traits in individual seeds or plant extracts.
- the invention provides significant improvements in the accuracy, speed and resolution of traits in agricultural samples.
- An aspect of the invention provides methods for analyzing agricultural samples.
- the invention is used to analyze genetic traits in agricultural samples, such as seeds, leaf punches, and the like.
- An agricultural sample preparation is mixed in a first fluid.
- the first fluid is placed in a fluidic channel that terminates in a chamber housing a second fluid that is immiscible with the first fluid.
- Reagents are introduced via another fluidic channel.
- a mixed droplet is formed that contains the sample and reagents wrapped in the immiscible fluid.
- the droplet can then exit via an exit channel for analysis. Analysis can occur in the channel or in a separate chamber or device.
- An exemplary immiscible second fluid is oil.
- the agricultural sample can be a seed, a batch of seeds, a portion of a seed, or a seed scraping.
- the agricultural sample can also include plant tissue, such as a leaf, a leaf punch, a flower, a root, and a petal.
- the agricultural sample includes non-plant based material, such as a fungal sample.
- the desired trait to be analyzed can be a biochemical trait.
- Exemplary biochemical traits include oil content, protein content, carbohydrate content, starch content, fiber content, water content, amino acid content, fatty acid content, nitrogen content, chlorophyll fluorescence, metabolites, oil composition, protein composition, carbohydrate composition, and fiber composition.
- the desired trait can be linked to a genetic marker.
- Reagents used to detect a desired trait are selected according to knowledge in the art to support the assay being performed.
- selected reagents can be a labeled antibody, a nucleic acid probe, a prime, a polymerase, a buffer, etc., and mixtures necessary to carry out a specified reaction or set of reactions.
- Another aspect of the invention provides methods for determining traits in a progeny agricultural sample.
- Nucleic acid from a progeny agricultural sample in a first fluid is introduced into a liquid bridge for mixing with at least one reagent to form a mixed droplet that is wrapped in an immiscible second fluid.
- Nucleic acid is isolated in respective droplets for analysis. Analysis can take any desired form, such as hybrid capture, PCR, single base extension, and others.
- Another aspect of the invention provides a method for analyzing an environmental sample for presence of a biological agent including, providing a liquid bridge for mixing an aliquot of an environmental sample in a first fluid with at least one reagent to form a mixed droplet that is wrapped in an immiscible second fluid, and analyzing the mixed droplet to detect presence or absence of a biological agent in the environmental sample.
- the method can further include, prior to the providing step, obtaining a gene or gene product from the biological agent in the environmental sample.
- the method can further include, prior to the analyzing step, performing PCR on the gene from the biological agent in the mixed droplet.
- Exemplary environmental samples include a water sample or a soil sample.
- a biological agent include all genuses and species of bacteria and fungi, including, for example, all spherical, rod-shaped and spiral bacteria.
- Exemplary bacteria are stapylococci (e.g., Staphylococcus epidermidis and Staphylococcus aureus), Enterrococcus faecalis, Pseudomonas aeruginosa, Escherichia coli, other gram-positive bacteria, and gram-negative bacilli.
- An exemplary fungus is Candida albicans.
- a biological agent also includes toxins secreted by bacteria or fungi. For example, E.
- a biological agent can also include an allergen.
- An allergen is a nonparasitic antigen capable of stimulating an immune response in a subject. Allergens can include plant pollen or dust mite excretion.
- FIG. 1 is a drawing depicting an exemplary embodiment of a liquid bridge having two inlets and one outlet.
- FIG. 2 is a drawing depicting another exemplary embodiment of a liquid bridge having two inlets and one outlet.
- FIG. 3 is a drawing depicting an exemplary embodiment of a liquid bridge having one inlet and two outlets.
- FIG. 4 is a sequence of photographs showing liquid dynamics and dimensions at a liquid bridge.
- FIG. 5 is a diagram showing a characteristic plot of volumetric ratio vs. slenderness at a liquid bridge for segmentation.
- FIG. 6 is a set of photographs of liquid bridge segmentors having different geometries.
- FIG. 7 is a characteristic plot for a liquid bridge segmentor.
- FIG. 8 is a collapsed data characteristic plot for liquid bridge segmentation.
- FIG. 9 is a further characteristic plot for a liquid bridge segmentor.
- FIG. 10 is a set of photographs of three liquid bridge segmentors having different capillary radii.
- FIG. 11 is a further characteristic plot for a liquid bridge segmentor.
- FIG. 12 is a photograph of a funicular bridge, also showing dimension parameters.
- FIG. 13 is a funicular liquid bridge characteristic stability plot.
- the present invention generally relates to methods for analyzing agricultural and/or environmental samples using liquid bridges.
- An aspect of the invention provides a method for analyzing an agricultural sample for a desired trait.
- An agricultural sample includes any plant material that is being interrogated by a method of the present invention.
- An agricultural sample includes, but is not limited to, seeds or plant tissue. Seeds include a single seed, a batch of seeds, a portion of a seed, or a seed scraping.
- the seed can be any type of seed, such as alfalfa seed, apple seed, banana seed, barley seed, bean seed, broccoli seed, castorbean seed, citrus seed, clover seed, coconut seed, coffee seed, maize seed, cotton seed, cucumber seed, Douglas fir seed, Eucalyptus seed, Loblolly pine seed, linseed seed, melon seed, oat seed, olive seed, palm seed, pea seed, peanut seed, pepper seed, poplar seed, Radiata pine seed, rapeseed seed, rice seed, rye seed, sorghum seed, Southern pine seed, soybean seed, strawberry seed, sugarbeet seed, sugarcane seed, sunflower seed, sweetgum seed, tea seed, tobacco seed, tomato seed, turf, wheat seed, and Arabidopsis thaliana seed.
- alfalfa seed alfalfa seed
- apple seed banana seed
- barley seed bean seed
- bean seed broccoli seed
- castorbean seed citrus seed
- clover seed coconut seed
- Coffee seed mai
- Plant tissue includes, but is not limited to, any plant part such as leaf, flower, root, or petal. Plant tissue can also include a leaf punch. The plant tissue can by from any plant, such as alfalfa, barley, canola, corn, cotton, oats, potato, rice, rye, soybean, sugarbeet, sunflower, sorghum, and wheat.
- An agricultural sample also includes non-plant based material such as nonorganic matter or non-plant based matter that occurs in an agricultural context. Fungal samples are also examples of an agricultural sample.
- Methods of the invention involve obtaining a sample comprising a gene, gene product, or other marker from an agricultural sample.
- DNA may be extracted from the agricultural sample using any DNA extraction methods known to those of skill in the art that will provide sufficient DNA yield, and DNA quality.
- a non-limiting example of suitable DNA extraction methods is SDS-based extraction with centrifugation.
- Bhat et al. (US 7,208,654, the contents of which are incorporated by reference herein in their entirety) provides another exemplary method for extracting DNA from an agricultural sample. Briefly, to extract DNA, REDExtract-N-Amp Plant PCR kit (Cat # XNA-P, Sigma, 3050 Spruce Street, St. Louis, Mo.
- DNA is extracted as follows: 100 ⁇ l of Extraction Solution is added to a vessel containing a leaf punch and the vessel is covered with a plate sealer. The vessel is heated to 95 0 C for 10 minutes in a heat block. The vessel is then cooled to room temperature and then again heated at 95 0 C for 10 minutes. The vessel is cooled to room temperature and then spun in a microfuge before removing the sealer. To each well an equal amount of Dilution buffer is added (provided in the kit).
- the sample can be introduced into the liquid bridge "in situ", that is without preparation. However, in many embodiments, it is desirable to process the sample prior to isolating the analyte to be detected.
- the agricultural sample can be crushed, pulverized, ground, cut, punched, scraped, etc.
- Methods for manipulating agricultural samples are well known in the art. See, for example, Bhat et al. (US 7,208,654), Deppermann et al. (US 7,502,113), Armstrong et al. (US 6,603,061), Feng et al. (US 6,107,549), Frayley et al. (US 6,255,560), Kotyk et al.
- the gene or gene product is obtained from a seed scraping. Seed scraping can be performed manually or by using a machine. Methods and systems for obtaining a seed scraping are shown in Deppermann et al. (US 7,502,113).
- Methods of the invention further include providing a liquid bridge for mixing the gene or gene product with at least one reagent to form a mixed droplet that is wrapped in an immiscible carrier fluid.
- a liquid bridge includes a chamber having at least one inlet and at least one outlet.
- the chamber can include as many inlets and outlets as are desired, for example, one inlet and one outlet, two inlets and two outlets, three inlets and three outlets, four inlets and four outlets, one inlet and two outlets, one inlet and three outlets, one inlet and four outlets, two inlets and one outlet, etc.
- the liquid bridge chamber and its inlets and outlets can be composed of any inert material that does not interact with the sample or the carrier fluid.
- exemplary materials include polytetrafluoroethylene (PTFE; commercially available from Dupont, Wilmington, DE), polyetheretherketone (PEEK; commercially available from TexLoc, Fort Worth, TX), perfluoroalkoxy (PFA; commercially available from TexLoc, Fort Worth, TX), or Fluorinated ethylene propylene (FEP; commercially available from TexLoc, Fort Worth, TX).
- the chamber is configured to receive a carrier fluid, the carrier fluid filling a space in the chamber between the inlet and the outlet.
- the carrier fluid is immiscible with the sample.
- an exemplary carrier fluid is an oil, for example silicone oil.
- the silicone oil is PD5 oil.
- the oil is any oil that contains a phenol group.
- the sample can be hydrophobic and exemplary carrier fluids include water or alcohol such as methanol or ethanol.
- the carrier fluid is density matched with the sample such that a neutrally buoyant environment is produced within the chamber.
- the carrier fluid is an oil
- the oil typically provides a pressure of no more than 0.5 to 1.0 bar above atmospheric pressure.
- the oil generally has a viscosity of about 0.08 Pas to about 0.1 Pas.
- the inlets and outlets can be of any shape, for example, circular, rectangular, triangular, or square.
- the inlets and outlets can have an inner diameter ranging from about 10 ⁇ m to about 3 mm.
- the inlets an outlets have an inner diameter of about 10 ⁇ m, about 50 ⁇ m, about 100 ⁇ m, about 150 ⁇ m, about 200 ⁇ m, about 400 ⁇ m, about 600 ⁇ m, about 900 ⁇ m, about 1 mm, about 2 mm, or about 3 mm.
- the inlets and outlets have the same inner diameter.
- the inlets and outlets have different inner diameters.
- each of the inlets have different inner diameters.
- each of the outlets have different inner diameters.
- FIG. 1 shows an exemplary embodiment of a liquid bridge having two inlets and one outlet.
- a bridge 1 includes a first inlet 2, a narrower second inlet 3, an outlet 4, and a chamber 5.
- the chamber is filled with a carrier fluid, e.g., silicone oil, and the carrier fluid is density- matched with the first sample 6 such that a neutrally buoyant environment is created within the chamber 5.
- the oil within the chamber is continuously replenished by the oil separating formed droplets of sample. Replenishment of the oil separating the formed droplets results in the droplets assuming a stable capillary- suspended spherical form upon entering the chamber 5.
- FIG. 1 panels B and C show that the spherical shape of the sample grows until large enough to span the gap between the ports, forming an axisymmetric liquid bridge.
- FIG. 1 panel D shows that introduction of a second sample droplet 7 from the second inlet 3 results in formation of an unstable funicular bridge.
- FIG. 1 panel E shows that the unstable funicular bridge quickly ruptures from the second inlet 3, and the first and second sample droplets combine at the liquid bridge 1.
- FIG. 1 panels F and G show that upon combination with the first sample 6 and the second sample 7, the droplet 8 containing each of the first sample 6 and the second sample 7 ruptures from the first inlet 2 and enters the outlet 4.
- the first inlet 2 and the outlet 3 are of diameter 200 ⁇ m.
- the separation of the inlet 2 and the outlet 4 is about 1 mm.
- the second inlet 3 is of diameter 100 ⁇ m, and the distance between the second inlet 3 and the axis of the inlet 2 and the outlet 4 is 1.5 mm.
- the chamber 5 is 5 mm in diameter and 3 mm in depth.
- the carrier fluid e.g., oil provides a pressure of no more than 0.5 to 1.0 bar above atmospheric, and has a viscosity of 0.08 to 0.1 Pas.
- the flow rate of the samples 6 and 7 entering chamber 5 is in the range of 2 ⁇ l/min to 5 ⁇ l/min.
- the carrier fluid is density-matched with each of samples 6 and 7 such that a neutrally buoyant environment is created within the chamber 5.
- the pressure in the chamber 5 is atmospheric.
- the interfacial tension within the chamber 5 is important for effective mixing of samples 6 and 7.
- the relative viscosity between the samples and carrier fluid is important.
- the internal pressure (Laplace pressure) within each droplet is inversely proportional to the droplet radius. Thus there is a higher internal pressure within the droplet at the second inlet 3. Because sample 6 and sample 7 are of the same phase, there is little interfacial tension between the droplets of these fluids. Thus, the internal pressures cause a joining of the droplets, akin to injection of one into the other. Also, physical control of the locations of the sample droplets 6 and 7 is achieved by the carrier fluid, which is immiscible with the droplets.
- a surfactant can be added to either the samples 6 and 7 or the carrier fluid to change the interfacial tension.
- FIG. 2 shows another exemplary embodiment of a liquid bridge having two inlets and one outlet.
- liquid bridge 9 includes a first inlet 10, a second inlet 11, an outlet 12, and a chamber 13.
- the chamber 13 is filled with a carrier fluid, e.g., silicone oil.
- the chamber 13 is 5 mm in diameter and 3 mm in depth, and the internal pressure caused by flow of carrier fluid, e.g., silicone oil, from the second inlet 11 into the chamber 13 is no more than 0.5 bar to 1.0 bar above atmospheric pressure.
- the diameter of the inlets 10 and 11 and outlet 12 is 200 ⁇ m.
- the spacing between the first inlet 10 and the outlet 12 is 0.5 mm.
- the spacing between these ports can range from 0.2 mm to 1.5 mm.
- the flow rate of the sample from the inlet 10 into the chamber 13 is 5 ⁇ l/min.
- the flow rate can generally range from about 2 ⁇ l/min to about 8 ⁇ l/min.
- FIG. 2 panel A shows that an sample droplet 14 is initially formed at the end of the inlet 10. As shown in FIG. 2 panel B, the sample droplet 14 momentarily bridges between the inlet 10 and the outlet 12. The volume held in this bridge is then steadily reduced by the action of pumping carrier fluid into the chamber through the second inlet port 11.
- FIG. 2, panels B and C show that pumping carrier fluid into the chamber while the sample droplet 14 momentarily bridges between the inlet port 10 and the outlet port 12 results in the formation of an unstable liquid bridge that ruptures to release a microfluidic plug 15 of sample that enters the outlet 12.
- FIG. 2 panel D shows that subsequent to rupture of the microfluidic plug 15, the process repeats itself with the formation of another sample droplet 16 at the end of inlet 10.
- mixing of sample droplets may be achieved using a configuration in which a chamber includes one inlet and two outlets. Sample droplets entering the chamber through the inlet are close together, and the delay for droplet formation within the chamber due to a reduction in fluid flow through a main line results in a collision and hence mixing. Such mixing may be caused by withdrawal of oil from the chamber, or upstream of it.
- a liquid bridge 17 has an inlet 18, a first outlet 19, a second outlet 20, and a chamber 21.
- the chamber is filled with carrier fluid, e.g., oil, that is immiscible with the sample.
- a leading droplet of sample entering the chamber 21 through the inlet 18 forms a sample droplet 22 in the chamber at the end of the inlet 18.
- carrier fluid e.g., oil
- FIG. 3 panels B and C show that as carrier fluid, e.g., oil, is withdrawn from the chamber 21 through the second outlet 20, a smaller trailing sample droplet 23 collides with the leading sample droplet 22 so that the mixing occurs.
- FIG. 3 panel D shows a larger mixed sample droplet 24 leaving the chamber 21 via the first outlet 19.
- a density matched carrier fluid e.g., oil.
- the diameter of the inlet 18 and the outlets 19 and 20 is 250 ⁇ m.
- the spacing between the inlet 18 and the outlet 19 is about 1 mm.
- the spacing between the inlet and outlet can range from 0.2 mm to 1.5 mm.
- the carrier fluid is controlled to have a pressure of about 0.5 bar to about 1.0 bar above atmospheric.
- the carrier fluid e.g., silicone oil, has a viscosity of 0.08 to 0.1 Pas.
- sample droplets are enveloped by carrier fluid entering and exiting the bridge 17 via a protective film of the carrier fluid firm around the sample droplets. This provides a non-contacting solid surface that prevents carryover contamination from one sample droplet to the next sample droplet.
- the carrier fluid is used as the control fluid and is density-matched with the sample plugs such that a neutrally buoyant environment is created within the chamber.
- the second outlet 20 removes a flow of carrier fluid, e.g., oil, from the chamber causing the first sample droplet to slow and remain as a spherical shape at the first outlet 19.
- carrier fluid e.g., oil
- the first and second sample droplets can form as one and create an axisymmetric liquid bridge (FIG. 3, panel C).
- the mixed droplet then exits through the outlet port 19 (FIG. 3, panel D).
- the flow conditions should be adjusted such that flow through the inlet 18 is greater than the flow through the second outlet 20.
- a typical flow through the inlet port 18 is about 5 ⁇ l/min, and can generally range from about 2 ⁇ l/min to about 7 ⁇ l/min.
- the flow away from the chamber 21 through the second outlet 20 is typically 2.5 ⁇ l/min and can generally range from about 1 ⁇ l/min to about 5 ⁇ l/min. Since there is conservation of mass flow within the bridge, this means that the flow through the first outlet 19 will balance the bridge to give a flow of typically 2.5 ⁇ l/min, and can generally range from about 1 ⁇ l/min to about 5 ⁇ l/min.
- the liquid bridge 17 can be used with a constant outlet flow rate through the second outlet 20.
- droplets can be mixed and the fluid flow through the system can be decreased.
- liquid bridge 17 can be used in conjunction with a sensor to time the withdrawal of fluid through the second outlet 20 so as to maintain a generally constant sample flow rate.
- the sensor used can be a droplet detection sensor that includes a LED and photodiode.
- the LED is projected directly onto the center of the tube.
- a photodiode is positioned directly opposite the LED to pick up the light refracted through the rube.
- the carrier fluid e.g., oil
- Liquid bridge systems of the invention can further include at least one robotics system to control the gas-free sampling devices.
- the robotics systems control movement of the sampling device between wells of the first and second arrays and also control sample acquisition.
- At least one pump is connected to the sampling device.
- An exemplary pump is shown in Davies et al. (WO 2007/091229, the contents of which are incorporated by reference herein in their entirety). Other commercially available pumps can also be used.
- the pumps are controlled by a flow controller, e.g., a PC running WinPumpControl software (Open Cage Software, Inc., Huntington, NY), for control of direction of flow and flow rates.
- WinPumpControl software Open Cage Software, Inc., Huntington, NY
- Liquid bridge systems can be fluidly connected, e.g., tubes or channels, to an type of analysis device.
- the liquid bridge system is connected to a thermocycler to perform PCR reactions on the acquired sample.
- An exemplary thermocycler and methods of fluidly connecting a thermocycler to a liquid bridge system are shown in Davies et al. (WO 2005/023427, WO 2007/091230, and WO 2008/038259, the contents of each of which is incorporated by reference herein in its entirety).
- the thermocycler can be connected to an optical detecting device to detect the products of the PCR reaction.
- An optical detecting device and methods for connecting the device to the thermocycler are shown in Davies et al. (WO 2007/091230 and WO 2008/038259, the contents of each of which is incorporated by reference herein in its entirety).
- the system is configured to perform single molecule detection, including digital PCR.
- Liquid bridge systems of the invention are useful in application in which one desires to detect and/or analyze a small number of analytes, down to the single molecule level.
- the invention is useful for the detection of a desired analyte (e.g., a protein, a nucleic acid, a carbohydrate, or other biomarkers) in a heterogeneous sample.
- a desired analyte e.g., a protein, a nucleic acid, a carbohydrate, or other biomarkers
- One important application of single molecule detection is digital nucleic acid amplification. Digital amplification and digital PCR are shown in Davies et al. (WO 2007/091230).
- Digital amplification is the process in which one amplifies a single nucleic acid template in order to generate a clonal population of amplicons. Digital amplification is useful to identify template molecules in samples, such as complex heterogeneous samples (e.g., urine, sputum, stool, puss, blood, or other bodily fluids); or to monitor a PCR reaction.
- complex heterogeneous samples e.g., urine, sputum, stool, puss, blood, or other bodily fluids.
- Digital PCR uses use fluorescent probes to monitor the amplification process as it progresses.
- SYBR Green 1 dye is an exemplary dye used for fluorescent detection of double stranded DNA generated during PCR.
- important information regarding the DNA sample is obtained. This is accomplished by illuminating the sample and detecting the resulting fluorescence. Different product concentration will demonstrate fluorescence amplification at difference cycle numbers.
- An exemplary system for digital PCR is disclosed in Davies et al. (WO 2007/091230). Methods of the invention further include analyzing the mixed droplet to detect a desired trait of the agricultural sample.
- the desired trait to be detected can be a biochemical trait, a marker, or a genotype.
- biochemical traits include oil content, protein content, carbohydrate content, starch content, fiber content, water content, amino acid content, fatty acid content, nitrogen content, chlorophyll fluorescence, metabolites, oil composition, protein composition, carbohydrate composition, and fiber composition.
- the desired trait is linked to a genetic marker.
- the desired trait is detected by extracting DNA from the agricultural samples, and screening the DNA for the presence or absence of the genetic marker.
- a wide variety of genetic markers are available and known to those of skill in the art. The screening may be used to select for quantitative trait loci (QTL), alleles, or genomic regions (haplotypes).
- the desired trait is linked to the presence or absence of a genetic marker that is genetically linked with a QTL.
- QTLs which are often of interest include but are not limited to yield, lodging resistance, height, maturity, disease resistance, pest resistance, resistance to nutrient deficiency, and grain composition.
- the desired trait is linked to the presence or absence of a marker that is genetically linked with a haplotype associated with a QTL. Examples of such QTL may again include without limitation yield, lodging resistance, height, maturity, disease resistance, pest resistance, resistance to nutrient deficiency, and grain composition.
- selectable or screenable marker genes include genes that encode a secretable marker whose secretion can be detected as a method of identifying or selecting for transformed cells in an agricultural sample. Examples include markers that encode a secreted antigen that can be identified by antibody interaction, or even secreted enzymes that can be detected catalytically.
- Secreted proteins fall into a number of classes, including small, diffusible proteins detectable, e.g., by ELISA, small active enzymes detectable in extracellular solution (e.g., _-amylase, _-lactamase, phosphinothricin transferase), or proteins that are inserted or trapped in the cell wall (such as proteins which include a leader sequence such as that found in the expression unit of extension or tobacco PR-S).
- small active enzymes detectable in extracellular solution e.g., _-amylase, _-lactamase, phosphinothricin transferase
- proteins that are inserted or trapped in the cell wall such as proteins which include a leader sequence such as that found in the expression unit of extension or tobacco PR-S.
- Other possible selectable and/or screenable marker genes will be apparent to those of skill in the art.
- agents are useful in analyzing and detecting analytes in the sample (e.g., a desired trait).
- agents include, for example, polynucleotides, polypeptides, small molecules, and/or antibodies useful in in situ screening assays for detecting the desired trait.
- An agent can be detectably labeled such that the agent is detectable when bound or hybridized to its target biomarker or ligand. Detectably labeling any of the foregoing agents includes an enzymatic, fluorescent, or radionucleotide label. Other reporter methods and labels are well known in the art.
- an agent useful in the methods of the invention can be an antibody.
- antibody as referred to herein includes whole antibodies and any antigen binding fragment (i.e., "antigen binding portion") or single chains of these.
- a naturally occurring “antibody” is a glycoprotein including at least two heavy (H) chains and two light (L) chains inter-connected by disulfide bonds.
- Antibodies useful in the methods of the invention include intact polyclonal or monoclonal antibodies, as well as fragments thereof, such as Fab and F(ab')2.
- monoclonal antibodies are made from antigen containing fragments of a protein by methods well known to those skilled in the art (Kohler, et al., Nature, 256:495, 1975; and Harlow et al., Antibodies, Cold Spring Harbor Laboratory, pp. 93-117, 1988).
- Fluorescent molecules may be bound to an immunoglobulin either directly or indirectly by using an intermediate functional group.
- An agent useful in the methods of the invention can also be a nucleic acid molecule (e.g., an oligonucleotide or polynucleotide probe).
- a nucleic acid molecule e.g., an oligonucleotide or polynucleotide probe.
- in situ nucleic acid hybridization techniques are well known in the art and can be used to identify a RNA or DNA biomarker present in an agricultural sample. Screening procedures that rely on nucleic acid hybridization make it possible to identify a biomarker from any sample, provided the appropriate oligonucleotide or polynucleotide agent is available.
- oligonucleotide agents which can correspond to a part of a sequence encoding a target polypeptide, can be synthesized chemically or designed through molecular biology techniques.
- polynucleotide encoding the target polypeptide can be deduced from the genetic code, however, the degeneracy of the code must be taken into account.
- hybridization is typically performed under in situ conditions known to those skilled in the art.
- a number of fluorescent labels are known in the art and include DAPI, Cy3, Cy3.5, Cy5, CyS.5, Cy7, umbelliferone, fluorescein, fluorescein isothiocyanate (FITC), rhodamine, dichlorotriazinylamine fluorescein, dansyl chloride or phycoerythrin.
- a fluorescent label should have distinguishable excitation and emission spectra. Where two or more fluorescent labels are used, they should have differing excitation and emission spectra that differ, respectively, by some minimal value (typically about 15-30 nm). The degree of difference will typically be determined by the types of filters being used in the process. Typical excitation and emission spectra for DAPI, FITC, Cy3, Cy3.5, Cy5, CyS.5, and Cy7 are provided below in table 1.
- the reagents are PCR reagents.
- a typical Q-PCR reaction contains: fluorescent double- stranded binding dye, Taq polymerase, deoxynucleotides of type A, C, G, and T, magnesium chloride, forward and reverse primers and cDNA, all suspended within an aqueous buffer.
- Reactants may be assigned into two broad groups: universal and reaction specific. Universal reactants are those common to every Q-PCR reaction, and include: fluorescent double- stranded binding dye, Taq polymerase, deoxynucleotides A, C, G and T, and magnesium chloride. Reaction specific reactants include the forward and reverse primers and patient cDNA.
- Oligonucleotide primers refer to linear, single- stranded, oligomeric deoxyribonucleic or ribonucleic acid molecules capable of sequence-specific hybridization (annealing) with complementary strands of modified or unmodified nucleic acid.
- the specific primers are DNA.
- the primers of the invention embrace oligonucleotides of appropriate sequence and sufficient length so as to provide for specific and efficient initiation of polymerization (primer extension) during the amplification process.
- oligonucleotide primers typically contain 12-30 nucleotides or more, although may contain fewer nucleotides.
- primers are single-stranded although double- stranded primers may be used if the strands are first separated.
- Primers may be prepared using any suitable method, such as conventional phosphotriester and phosphodiester methods or automated embodiments which are commonly known in the art.
- the specific primers may be designed to be substantially complementary to each strand of the genomic locus of interest. Typically, one primer is complementary to the negative (-) strand of the locus (the "lower” strand of a horizontally situated double- stranded DNA molecule) and the other is complementary to the positve (+) strand ("upper” strand).
- Analytical methods of the invention allow individual seeds to be analyzed that are present in a batch or a bulk population of seeds such that the chemical and/or genetic traits of the individual seeds can be determined.
- Exemplary traits include starch content, protein content, oil content, determination of fatty acid profiles, etc.
- Methods of the present invention can also be used in a breeding program to select plants or seeds having a desired trait or marker genotype.
- the methods of the present invention can be used in combination with any breeding methodology and can be used to select a single generation or to select multiple generations.
- DNA is obtained from the seed and analyzed for the presence or absence of at least one genetic marker. Based on the results of the DNA screening, seeds can be selected from the population, and plants can be cultivated from the selected seed.
- the choice of breeding method depends on the mode of plant reproduction, the heritability of the trait(s) being improved, and the type of cultivar used commercially (e.g., Fl hybrid cultivar, pureline cultivar, etc).
- Exemplary traits that can be detected include emergence vigor, vegetative vigor, stress tolerance, disease resistance, branching, flowering, seed set, seed size, seed density, standability, and threshability etc.
- the methods of the present invention are used to determine the genetic characteristics of seeds in a marker-assisted breeding program.
- Methods of the invention may also be used for introgressing a trait into a plant by removing DNA from an agricultural sample, screening the DNA extracted from the sample for the presence or absence of at least one genetic marker, selecting seeds from the population based upon the results of the DNA screening, cultivating a fertile plant from the seed, and utilizing the fertile plant as either a female parent or male parent in a cross with another plant.
- genetic screening to select seeds for trait integration include, without limitation, identification of high recurrent parent allele frequencies, tracking of transgenes of interest or screening for the absence of unwanted transgenes, selection of hybrid testing seed, and zygosity testing.
- the identification of high recurrent pair allele frequencies via the screening methods of the present invention again allows for a reduced number of rows per population and an increased number of populations, or inbred lines, to be planted in a given field unit.
- the screening methods of the present invention may also effectively reduce the resources required to complete the conversion of inbred lines.
- the methods of the present invention further provide quality assurance and quality control by assuring that regulated or unwanted transgenes are identified and discarded prior to planting.
- the methods of the present invention may be further applied to identify hybrid seeds for transgene testing.
- a breeder could effectively create a hybrid seed lot (barring gamete selection) that was 50% hemizygous for the trait of interest and 50% homozygous for the lack of the trait in order to generate hybrid seeds for testing.
- the breeder could then screen all Fl seeds produced in the test cross and identify and select those seeds that were hemizygous.
- Such a method is advantageous in that inferences from the hybrid trials would represent commercial hybrid genetics with regard to trait zygosity.
- methods of the invention are used to determine ploidy of an organism.
- Ploidy refers to the number of complete sets of chromosomes in an organism, such as a plant. Plants can be, for example, haploid, diploid, triploid, tetraploid, polyploid, or aneuploid. Also, ploidy of cells can vary within an organism.
- a doubled haploid is an organism having two identical sets of chromosomes. Double haploids are produced from haploid pollen or egg cells that are induced to undergo chromosome doubling. Haploid cells occur naturally in the gametophytic phases of higher plants in their ovules and pollen. By manipulating the gametic cells, it is possible to produce homozygous embryos rather than mature pollen grains or ovules. By induced or spontaneous chromosome doubling, a completely homozygous doubled haploid plant can be produced.
- the invention further provides an assay for predicting embryo zygosity for a particular gene of interest. The assay predicts embryo zygosity based on the ratio of the relative copy numbers of a selected gene and an internal control gene per cell or per genome.
- this assay uses a control gene that is of known zygosity, for normalizing measurement of the selected gene.
- the ratio of the relative copy numbers of the control to the selected gene predicts the gene copy number in the cell.
- the gene copy number is equal to the ploidy of the cell since the sequence is present at the same locus in all homologous chromosomes.
- the gene copy number will be lower than the ploidy level of the cell. The zygosity of a cell at any locus can thus be determined by the gene copy number in the cell.
- Example 1 Rupturing of a sample in a liquid bridge
- Liquid bridge stability was studied as a means to predicting the geometric conditions at which rupture occurs.
- Liquid bridge rupture may be defined as the complete breakage of the liquid filament connecting one solid support to the other.
- the dimensionless parameters characterizing liquid bridges are used to define the stability boundary at which rupture was observed.
- FIG. 4 presents images of liquid bridges at three slenderness conditions just prior to rupture. The rupture was caused by the withdrawal of liquid bridge fluid from one capillary tube. It was observed that low slenderness ratio liquid bridges, an example of which is shown in FIG. 4, panel A, adopt a thimble shape at the minimum volume stability. Larger slenderness ratio liquid bridges, such as that shown in FIG. 4, panel C, possess a barrel form with a maximum radius at the bridge mid-span. Intermediate slenderness ratios were found to have a near cylindrical shape at the minimum volume stability limit.
- FIG. 4, panels A-C show liquid bridges with slenderness ratios of 1.09, 2.45 and 6.16 respectively.
- Example 2 Stability of a liquid bridge with respect to slenderness and volume
- FIG. 7 shows the approximate location of the minimum volume stability boundary for liquid bridges with a lateral Bond number of 1.25 x 10 ⁇ 4 , a near weightless environment. Vertical and horizontal error bars indicate experimental uncertainty.
- FIG. 4 panel C for example, bridges maintain their integrity and reach a minimum energy configuration.
- FIG. 4 panel A for example, the bridges break before the interfacial energy is minimized.
- the initial dip in the stability boundary at low slenderness ratios was caused by low-volume droplets not fully wetting the exposed fused silica of the capillary tips.
- the influence of unequal capillaries on the ⁇ *- V* stability diagram is also shown in FIG. 5. It can be seen that the unstable region of the ⁇ * - V* plane increases as the parameter K*, the ratio of capillary radii, decreases.
- the results presented in FIG. 5 confirmed that the static stability of liquid bridge is purely geometrical at low Bond numbers. It is notable that low slenderness ratio bridges are almost completely stable, with respect to rupture, for all capillary radii measured.
- FIG. 5 shows a stability diagram for a de-ionized water liquid bridge in a density matched silicone oil, Bond number: 1.25 x 10 ⁇ 4 .
- Vertical error bars indicate the volumetric ratio uncertainty as a result of camera frame rate.
- Horizontal error bars indicate slenderness uncertainty due to capillary tip misalignment.
- the parameter K* is the ratio of supporting capillary radii.
- liquid bridge instability as a mechanism for dispensing sub-microliter volumes of fluid in a continuous manner.
- the dispensing mechanism provided a reliable means of producing uniform aqueous plugs separated by silicone oil that did not rely on the shear force exerted by the carrier fluid.
- the repeatability with which the method dispensed plugs was examined.
- the approach used the liquid bridge's dependence on geometry to create a periodic instability between opposing capillary tips.
- a stable liquid bridge was first established between aqueous inlet and outlet. The volume held in this bridge was then steadily reduced by the action of the silicone oil inlet. This caused the formation of an unstable liquid bridge that ruptured to release a smaller plug at the outlet.
- the segmenting mechanism provided a reliable means of producing uniform aqueous plugs separated by silicone oil that did not rely on the shear force exerted by the carrier fluid. Furthermore, a protective oil film was established between the walls of the circular capillaries and the droplet to prevent carryover contamination.
- FIG. 6 panels A-D shows images of a liquid bridge dispensing at four different slenderness ratios.
- A* 0,
- B) A* 0.76
- C) A* 1.37
- D) A* 2.31.
- Q* 0.5
- K* 0.44.
- Increasing the capillary tip separation, and hence the slenderness ratio increased the plug volumes dispensed.
- Q* the oil flow rate as a fraction of the total flow rate, was maintained constant at 0.5.
- FIG. 6 panel A shows dispensing with the dispensing capillary inserted inside the outlet capillary. This configuration was assigned a slenderness ratio, A* of zero.
- FIG. 7 presents a plot of V*, against slenderness ratio, ⁇ * , where V* is the dimensionless plug volume scaled with RQ 3 , i.e.:
- V* V /R n
- Results are presented for three different values of the oil flow rate fraction, Q*, with the ratio of capillary tip radii, K*, maintained constant at 0.44.
- the axis on the right-hand side of the plot indicates the measured plug volume.
- Horizontal error bars indicate slenderness uncertainty as a result of positional inaccuracy.
- Vertical error bar are a result of uncertainty in the plug volume calculation due to image processing.
- the results show the expected trend of increased plug volume with liquid bridge slenderness ratio. Decreasing Q* resulted in a dramatic increase in dimensionless plug volume.
- Altering Q* also affected the volume of silicone oil separating the aqueous plugs as Q * is the oil flow rate as a fraction of the total flow rate.
- a thin film of the wetting fluid separated the droplets from the capillary surface.
- the thickness of the film resulted from a balance between the oil viscosity, ⁇ , and the interfacial tension, d .
- the thickness of the oil film deposited in a capillary of radius r is given by;
- the capillary number, Ca is given by:
- Equation (0.1) is obeyed if the film is thin enough to neglect geometric forces, h ⁇ 0. Ir , and thick enough to avoid the influence of long range molecular attraction, h>100 nm.
- Typical oil film thicknesses for plug flow through 400 ⁇ m polymeric fluorocarbon internal diameter tubing were calculated to be of the order of 1 ⁇ m.
- FIG. 8 presents a dimensionless plot of the product of V* and Q* versus ⁇ *.
- the data taken from the plot shown in FIG. 7, collapsed on to the trend line within the bounds of uncertainty.
- the data applied to geometries with K* 0.44. Notwithstanding this geometric constraint, the collapsed data did yield valuable design information.
- FIG. 10 panels A-C shows a liquid bridge dispensing at three different values for K*.
- Panels (A), (B) and (C) correspond to K* values of 0.25, 0.44 and 1.0 respectively.
- K* value of 0.25 was achieved by assembling a 200 ⁇ m fused silica microcapillary at the end of a polymeric capillary tube by a reduction of internal diameter through appropriately sized fused silica. Sealing was ensured with the addition of cyanoacrylate glue at the sleeve interfaces.
- FIG. 9 presents a dimensionless plot of V* versus ⁇ * for three different values of K*.
- the dimensionless plug volume, V* was scaled with R 2 3 , and not Ro 3 as previously. This permitted a direct comparison of dimensionless plug volumes as R 2 remained constant throughout the experiment. It was observed that decreasing K* generally lowered the plug volumes dispensed for any given value of slenderness, ⁇ *.
- the results show mean plug volumes of approximately 120 nL and 56 nL with maximum volumetric variations of ⁇ 4.46% and ⁇ 3.53% respectively.
- These volumetric variations compared favorably to commercial available micropipettes that have an uncertainty of ⁇ 12% when dispensing 200 nL.
- the accuracy with which one may dispense using micropipettes, however, is thought to be largely dependant upon user skill.
- the automation of dispensing systems may therefore be justified as a means of eliminating user-user variability.
- the volumetric analysis presented in FIG. 11 shows liquid bridge dispensing to be a very repeatable means of continuously dispensing sub-microliter volumes of fluid.
- FIG. 12 is an image of a liquid bridge.
- the bridge consisted of two opposing capillaries of the same external diameter.
- the second inlet part was of a finer capillary orientated at right angles to and situated half-way between the other two capillaries. Constraints on opposing capillary radius and the placement of the third capillary helped to simplify the dimensionless stability study. The investigation also necessitated modifications to the dimensionless parameters characterizing axisymmetric liquid bridge geometry.
- the slenderness ratio, ⁇ * was calculated using:
- R 0 is defined as the mean radius, i.e. (R 1 +R 2 ) /2.
- K* is defined as R 1 ZR 2 .
- the volumetric ratio, V* is defined as:
- ⁇ is the measured volume at which bridge collapse occurs.
- a funicular bridge collapse corresponded to detachment from the finer capillary.
- FIG. 13 shows a stability diagram for the approximate location of the minimum volume stability boundary for purified water funicular liquid bridges with a lateral Bond number of 1.25 x 10 ⁇ 4 , a near weightless environment.
- the boundaries of stability were found by fixing a value for ⁇ *, establishing a stable funicular bridge and withdrawing fluid until the bridge collapsed. The collapse was recorded via a CCD and the frame immediately following rupture was analyzed to measure the volume. The calculation of the bridge volume was simplified by the fact that the collapsed funicular bridge exhibited axisymmetry with respect to the axis of the two larger capillaries.
- the two input one output, funicular bridge can be configured so that the expression profile of many genes may be addressed.
- One input contains the primer and premix in a continuous phase, the outlet then delivers them in droplet form.
- many input and output capillaries, say p can be set in planes perpendicular to that of FIG. 1.
- a perpendicular arrangement allows for good optical access in the planar thermocycler which is connected to the output.
- Each arrangement of two inputs and one output can be used to address a single primer, giving p primers. This, however, would make for a very long device in the plane perpendicular to FIG. 1. If serially variant primers were fed into each input, numbering q , this would reduce the scale.
- N p x q x r.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Clinical Laboratory Science (AREA)
- Dispersion Chemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biotechnology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The present invention generally relates methods for analyzing agricultural and/or environmental samples using liquid bridges. In certain embodiments, the invention provides a method for analyzing an agricultural sample for a desired trait including obtaining a gene or gene product from an agricultural sample, in which the gene or gene product is in a first fluid; providing a liquid bridge for mixing the gene or gene product with at least one reagent to form a mixed droplet that is wrapped in an immiscible second fluid; and analyzing the mixed droplet to detect a desired trait of the agricultural sample.
Description
METHODS FOR ANALYZING AGRICULTURAL AND ENVIRONMENTAL SAMPLES USING MICROFLUIDIC SYSTEMS
Related Applications
The present invention claims the benefit of and priority to U.S. nonpro visional patent application serial number 12/469,339, filed May 20, 2009, the content of which is incorporated by reference herein in its entirety.
Field of Invention
The present invention generally relates to methods for analyzing agricultural and/or environmental samples using liquid bridges.
Background
In plant development, selective breeding or genetic manipulation are used to make genetic improvements in plants. After a desirable improvement is achieved, commercial quantities are produced by planting and harvesting seeds over several generations. Breeding for enhanced agricultural products involves analysis of a large number of samples from plants to identify those plants with the desired properties for use or advancement to the next generation. For example, analysis of bulk seed batches for certain traits, such as high oil content or protein content, on a single plant or ear, in conjunction with an appropriate breeding methodology such as recurrent selection, often allows for the selection and introduction of such traits into a commercial population. Although the analysis of these seed batches can be performed by various techniques, methods that are rapid and low cost are most desirable.
As agricultural companies continue to introduce a variety of traits into agricultural crops that provide unique compositions and increasing value to the grain and/or its downstream products, there is an increasing need for more sophisticated analysis systems and methods for detecting the traits throughout the value chain, i.e., research and development, seed production, grain production, and grain processing.
Summary The present invention provides methods and devices for improved agricultural analysis
and selective plant breeding. In general, the invention involves using liquid bridges to analyze agricultural and/or environmental samples. Liquid bridges are used to produce sample droplets that contain reaction components for rapid analysis of small sample volumes. Liquid bridges allow the formation of sample droplets by through the interaction of immiscible fluids. In a preferred embodiment, liquid bridges are used for high throughput analysis of single seeds, allowing for the analysis and identification of agricultural traits in individual seeds or plant extracts. The invention provides significant improvements in the accuracy, speed and resolution of traits in agricultural samples.
An aspect of the invention provides methods for analyzing agricultural samples. In a preferred embodiment, the invention is used to analyze genetic traits in agricultural samples, such as seeds, leaf punches, and the like. An agricultural sample preparation is mixed in a first fluid. The first fluid is placed in a fluidic channel that terminates in a chamber housing a second fluid that is immiscible with the first fluid. Reagents are introduced via another fluidic channel. As droplets containing sample and reagents converge on the chamber, a mixed droplet is formed that contains the sample and reagents wrapped in the immiscible fluid. The droplet can then exit via an exit channel for analysis. Analysis can occur in the channel or in a separate chamber or device.
An exemplary immiscible second fluid is oil. The agricultural sample can be a seed, a batch of seeds, a portion of a seed, or a seed scraping. The agricultural sample can also include plant tissue, such as a leaf, a leaf punch, a flower, a root, and a petal. In certain embodiments, the agricultural sample includes non-plant based material, such as a fungal sample. The desired trait to be analyzed can be a biochemical trait. Exemplary biochemical traits include oil content, protein content, carbohydrate content, starch content, fiber content, water content, amino acid content, fatty acid content, nitrogen content, chlorophyll fluorescence, metabolites, oil composition, protein composition, carbohydrate composition, and fiber composition. The desired trait can be linked to a genetic marker.
Reagents used to detect a desired trait are selected according to knowledge in the art to support the assay being performed. For example, selected reagents can be a labeled antibody, a nucleic acid probe, a prime, a polymerase, a buffer, etc., and mixtures necessary to carry out a specified reaction or set of reactions.
Another aspect of the invention provides methods for determining traits in a progeny
agricultural sample. Nucleic acid from a progeny agricultural sample in a first fluid is introduced into a liquid bridge for mixing with at least one reagent to form a mixed droplet that is wrapped in an immiscible second fluid. Nucleic acid is isolated in respective droplets for analysis. Analysis can take any desired form, such as hybrid capture, PCR, single base extension, and others.
Another aspect of the invention provides a method for analyzing an environmental sample for presence of a biological agent including, providing a liquid bridge for mixing an aliquot of an environmental sample in a first fluid with at least one reagent to form a mixed droplet that is wrapped in an immiscible second fluid, and analyzing the mixed droplet to detect presence or absence of a biological agent in the environmental sample. The method can further include, prior to the providing step, obtaining a gene or gene product from the biological agent in the environmental sample. The method can further include, prior to the analyzing step, performing PCR on the gene from the biological agent in the mixed droplet.
Exemplary environmental samples include a water sample or a soil sample. A biological agent include all genuses and species of bacteria and fungi, including, for example, all spherical, rod-shaped and spiral bacteria. Exemplary bacteria are stapylococci (e.g., Staphylococcus epidermidis and Staphylococcus aureus), Enterrococcus faecalis, Pseudomonas aeruginosa, Escherichia coli, other gram-positive bacteria, and gram-negative bacilli. An exemplary fungus is Candida albicans. A biological agent also includes toxins secreted by bacteria or fungi. For example, E. coli secretes Shiga-like toxin (Zhao et al., Antimicrobial Agents and Chemotherapy, 1522-1528, 2002) and C. Difficile secretes Exotoxin B (Sifferta et al. Microbes & Infection, 1159-1162, 1999). A biological agent can also include an allergen. An allergen is a nonparasitic antigen capable of stimulating an immune response in a subject. Allergens can include plant pollen or dust mite excretion.
Brief Description of the Drawings
FIG. 1 is a drawing depicting an exemplary embodiment of a liquid bridge having two inlets and one outlet.
FIG. 2 is a drawing depicting another exemplary embodiment of a liquid bridge having two inlets and one outlet.
FIG. 3 is a drawing depicting an exemplary embodiment of a liquid bridge having one
inlet and two outlets.
FIG. 4 is a sequence of photographs showing liquid dynamics and dimensions at a liquid bridge.
FIG. 5 is a diagram showing a characteristic plot of volumetric ratio vs. slenderness at a liquid bridge for segmentation.
FIG. 6 is a set of photographs of liquid bridge segmentors having different geometries.
FIG. 7 is a characteristic plot for a liquid bridge segmentor.
FIG. 8 is a collapsed data characteristic plot for liquid bridge segmentation.
FIG. 9 is a further characteristic plot for a liquid bridge segmentor.
FIG. 10 is a set of photographs of three liquid bridge segmentors having different capillary radii.
FIG. 11 is a further characteristic plot for a liquid bridge segmentor.
FIG. 12 is a photograph of a funicular bridge, also showing dimension parameters.
FIG. 13 is a funicular liquid bridge characteristic stability plot.
Detailed Description
The present invention generally relates to methods for analyzing agricultural and/or environmental samples using liquid bridges. An aspect of the invention provides a method for analyzing an agricultural sample for a desired trait. An agricultural sample includes any plant material that is being interrogated by a method of the present invention. An agricultural sample includes, but is not limited to, seeds or plant tissue. Seeds include a single seed, a batch of seeds, a portion of a seed, or a seed scraping. The seed can be any type of seed, such as alfalfa seed, apple seed, banana seed, barley seed, bean seed, broccoli seed, castorbean seed, citrus seed, clover seed, coconut seed, coffee seed, maize seed, cotton seed, cucumber seed, Douglas fir seed, Eucalyptus seed, Loblolly pine seed, linseed seed, melon seed, oat seed, olive seed, palm seed, pea seed, peanut seed, pepper seed, poplar seed, Radiata pine seed, rapeseed seed, rice seed, rye seed, sorghum seed, Southern pine seed, soybean seed, strawberry seed, sugarbeet seed, sugarcane seed, sunflower seed, sweetgum seed, tea seed, tobacco seed, tomato seed, turf, wheat seed, and Arabidopsis thaliana seed.
Plant tissue includes, but is not limited to, any plant part such as leaf, flower, root, or petal. Plant tissue can also include a leaf punch. The plant tissue can by from any plant, such as
alfalfa, barley, canola, corn, cotton, oats, potato, rice, rye, soybean, sugarbeet, sunflower, sorghum, and wheat. An agricultural sample also includes non-plant based material such as nonorganic matter or non-plant based matter that occurs in an agricultural context. Fungal samples are also examples of an agricultural sample.
Methods of the invention involve obtaining a sample comprising a gene, gene product, or other marker from an agricultural sample. Methods of obtaining genes and/or gene products from agricultural samples are well known in the art. DNA may be extracted from the agricultural sample using any DNA extraction methods known to those of skill in the art that will provide sufficient DNA yield, and DNA quality. A non-limiting example of suitable DNA extraction methods is SDS-based extraction with centrifugation. Bhat et al. (US 7,208,654, the contents of which are incorporated by reference herein in their entirety) provides another exemplary method for extracting DNA from an agricultural sample. Briefly, to extract DNA, REDExtract-N-Amp Plant PCR kit (Cat # XNA-P, Sigma, 3050 Spruce Street, St. Louis, Mo. 63103 USA) can be used. DNA is extracted as follows: 100 μl of Extraction Solution is added to a vessel containing a leaf punch and the vessel is covered with a plate sealer. The vessel is heated to 95 0C for 10 minutes in a heat block. The vessel is then cooled to room temperature and then again heated at 95 0C for 10 minutes. The vessel is cooled to room temperature and then spun in a microfuge before removing the sealer. To each well an equal amount of Dilution buffer is added (provided in the kit).
The sample can be introduced into the liquid bridge "in situ", that is without preparation. However, in many embodiments, it is desirable to process the sample prior to isolating the analyte to be detected. For example, the agricultural sample can be crushed, pulverized, ground, cut, punched, scraped, etc. Methods for manipulating agricultural samples are well known in the art. See, for example, Bhat et al. (US 7,208,654), Deppermann et al. (US 7,502,113), Armstrong et al. (US 6,603,061), Feng et al. (US 6,107,549), Frayley et al. (US 6,255,560), Kotyk et al. (US 7,367,155), Modiano et al. (US 6,646,264), Modiano et al. (US 2007/0240242), and Das et al. (US 2009/0075325), the contents of each of which is incorporated by reference herein in their entirety. In certain embodiments, the gene or gene product is obtained from a seed scraping. Seed scraping can be performed manually or by using a machine. Methods and systems for obtaining a seed scraping are shown in Deppermann et al. (US 7,502,113).
Methods of the invention further include providing a liquid bridge for mixing the gene or
gene product with at least one reagent to form a mixed droplet that is wrapped in an immiscible carrier fluid. Exemplary liquid bridges are shown in Davies et al. (WO 2007/091228, the contents of which are incorporated by reference herein in their entirety). In certain embodiments, a liquid bridge includes a chamber having at least one inlet and at least one outlet. The chamber can include as many inlets and outlets as are desired, for example, one inlet and one outlet, two inlets and two outlets, three inlets and three outlets, four inlets and four outlets, one inlet and two outlets, one inlet and three outlets, one inlet and four outlets, two inlets and one outlet, etc.
The liquid bridge chamber and its inlets and outlets can be composed of any inert material that does not interact with the sample or the carrier fluid. Exemplary materials include polytetrafluoroethylene (PTFE; commercially available from Dupont, Wilmington, DE), polyetheretherketone (PEEK; commercially available from TexLoc, Fort Worth, TX), perfluoroalkoxy (PFA; commercially available from TexLoc, Fort Worth, TX), or Fluorinated ethylene propylene (FEP; commercially available from TexLoc, Fort Worth, TX).
The chamber is configured to receive a carrier fluid, the carrier fluid filling a space in the chamber between the inlet and the outlet. The carrier fluid is immiscible with the sample. In embodiments in which the sample is hydrophilic, an exemplary carrier fluid is an oil, for example silicone oil. In certain embodiments, the silicone oil is PD5 oil. In other embodiments, the oil is any oil that contains a phenol group. Alternatively, the sample can be hydrophobic and exemplary carrier fluids include water or alcohol such as methanol or ethanol.
In certain embodiments, the carrier fluid is density matched with the sample such that a neutrally buoyant environment is produced within the chamber. In embodiments in which the carrier fluid is an oil, the oil typically provides a pressure of no more than 0.5 to 1.0 bar above atmospheric pressure. The oil generally has a viscosity of about 0.08 Pas to about 0.1 Pas. The inlets and outlets can be of any shape, for example, circular, rectangular, triangular, or square. The inlets and outlets can have an inner diameter ranging from about 10 μm to about 3 mm. For example, the inlets an outlets have an inner diameter of about 10 μm, about 50 μm, about 100 μm, about 150 μm, about 200 μm, about 400 μm, about 600 μm, about 900 μm, about 1 mm, about 2 mm, or about 3 mm. In certain embodiments, the inlets and outlets have the same inner diameter. In other embodiments, the inlets and outlets have different inner diameters. In certain embodiments, each of the inlets have different inner diameters. In certain
embodiments, each of the outlets have different inner diameters.
The inlet(s) and outlet(s) have dimensions and are positioned in the chamber such that a sample periodically bridges from the inlet(s) to the outlet(s), and droplets of the sample are periodically delivered to the outlet(s). FIG. 1 shows an exemplary embodiment of a liquid bridge having two inlets and one outlet. Referring to FIG. 1 panel A, a bridge 1 includes a first inlet 2, a narrower second inlet 3, an outlet 4, and a chamber 5. The chamber is filled with a carrier fluid, e.g., silicone oil, and the carrier fluid is density- matched with the first sample 6 such that a neutrally buoyant environment is created within the chamber 5. The oil within the chamber is continuously replenished by the oil separating formed droplets of sample. Replenishment of the oil separating the formed droplets results in the droplets assuming a stable capillary- suspended spherical form upon entering the chamber 5.
FIG. 1 panels B and C show that the spherical shape of the sample grows until large enough to span the gap between the ports, forming an axisymmetric liquid bridge. FIG. 1 panel D shows that introduction of a second sample droplet 7 from the second inlet 3 results in formation of an unstable funicular bridge. FIG. 1 panel E shows that the unstable funicular bridge quickly ruptures from the second inlet 3, and the first and second sample droplets combine at the liquid bridge 1. FIG. 1 panels F and G show that upon combination with the first sample 6 and the second sample 7, the droplet 8 containing each of the first sample 6 and the second sample 7 ruptures from the first inlet 2 and enters the outlet 4.
In further detail, the first inlet 2 and the outlet 3 are of diameter 200 μm. The separation of the inlet 2 and the outlet 4 is about 1 mm. The second inlet 3 is of diameter 100 μm, and the distance between the second inlet 3 and the axis of the inlet 2 and the outlet 4 is 1.5 mm. The chamber 5 is 5 mm in diameter and 3 mm in depth. The carrier fluid, e.g., oil provides a pressure of no more than 0.5 to 1.0 bar above atmospheric, and has a viscosity of 0.08 to 0.1 Pas. The flow rate of the samples 6 and 7 entering chamber 5 is in the range of 2 μl/min to 5 μl/min. The carrier fluid is density-matched with each of samples 6 and 7 such that a neutrally buoyant environment is created within the chamber 5.
The pressure in the chamber 5 is atmospheric. The interfacial tension within the chamber 5 is important for effective mixing of samples 6 and 7. Also, the relative viscosity between the samples and carrier fluid is important. The internal pressure (Laplace pressure) within each droplet is inversely proportional to the droplet radius. Thus there is a higher internal pressure
within the droplet at the second inlet 3. Because sample 6 and sample 7 are of the same phase, there is little interfacial tension between the droplets of these fluids. Thus, the internal pressures cause a joining of the droplets, akin to injection of one into the other. Also, physical control of the locations of the sample droplets 6 and 7 is achieved by the carrier fluid, which is immiscible with the droplets. In certain embodiments, a surfactant can be added to either the samples 6 and 7 or the carrier fluid to change the interfacial tension.
FIG. 2 shows another exemplary embodiment of a liquid bridge having two inlets and one outlet. Referring to FIG. 2 panel A, liquid bridge 9 includes a first inlet 10, a second inlet 11, an outlet 12, and a chamber 13. The chamber 13 is filled with a carrier fluid, e.g., silicone oil. The chamber 13 is 5 mm in diameter and 3 mm in depth, and the internal pressure caused by flow of carrier fluid, e.g., silicone oil, from the second inlet 11 into the chamber 13 is no more than 0.5 bar to 1.0 bar above atmospheric pressure. The diameter of the inlets 10 and 11 and outlet 12 is 200 μm. The spacing between the first inlet 10 and the outlet 12 is 0.5 mm. The spacing between these ports can range from 0.2 mm to 1.5 mm. The flow rate of the sample from the inlet 10 into the chamber 13 is 5 μl/min. The flow rate can generally range from about 2 μl/min to about 8 μl/min.
The geometry between liquid bridge 9, and the carrier fluid create a periodic instability between the inlet 10 and the outlet 12 due to surface tension. FIG. 2 panel A shows that an sample droplet 14 is initially formed at the end of the inlet 10. As shown in FIG. 2 panel B, the sample droplet 14 momentarily bridges between the inlet 10 and the outlet 12. The volume held in this bridge is then steadily reduced by the action of pumping carrier fluid into the chamber through the second inlet port 11. FIG. 2, panels B and C show that pumping carrier fluid into the chamber while the sample droplet 14 momentarily bridges between the inlet port 10 and the outlet port 12 results in the formation of an unstable liquid bridge that ruptures to release a microfluidic plug 15 of sample that enters the outlet 12. FIG. 2 panel D shows that subsequent to rupture of the microfluidic plug 15, the process repeats itself with the formation of another sample droplet 16 at the end of inlet 10.
When the flow rate of the carrier fluid entering the chamber 13 from inlet port 12 is substantially the same as the flow rate of sample entering the chamber 13 from the inlet port 10, smaller segmented droplets, separated by the same volume of carrier fluid, e.g., silicone oil, are produced by the bridge 9. The segmenting mechanism reliably produces uniform aqueous
microfluidic plugs separated by carrier fluid that do not rely on the shear force exerted by the carrier fluid.
In another embodiment, mixing of sample droplets may be achieved using a configuration in which a chamber includes one inlet and two outlets. Sample droplets entering the chamber through the inlet are close together, and the delay for droplet formation within the chamber due to a reduction in fluid flow through a main line results in a collision and hence mixing. Such mixing may be caused by withdrawal of oil from the chamber, or upstream of it. Referring to FIG. 3, a liquid bridge 17 has an inlet 18, a first outlet 19, a second outlet 20, and a chamber 21. The chamber is filled with carrier fluid, e.g., oil, that is immiscible with the sample. A leading droplet of sample entering the chamber 21 through the inlet 18 forms a sample droplet 22 in the chamber at the end of the inlet 18. FIG. 3 panels B and C show that as carrier fluid, e.g., oil, is withdrawn from the chamber 21 through the second outlet 20, a smaller trailing sample droplet 23 collides with the leading sample droplet 22 so that the mixing occurs. FIG. 3 panel D shows a larger mixed sample droplet 24 leaving the chamber 21 via the first outlet 19. In more detail, initially, the entire system is primed with a density matched carrier fluid, e.g., oil. The diameter of the inlet 18 and the outlets 19 and 20 is 250 μm. The spacing between the inlet 18 and the outlet 19 is about 1 mm. The spacing between the inlet and outlet can range from 0.2 mm to 1.5 mm. The carrier fluid is controlled to have a pressure of about 0.5 bar to about 1.0 bar above atmospheric. The carrier fluid, e.g., silicone oil, has a viscosity of 0.08 to 0.1 Pas.
As with liquid bridges 1 and 9, sample droplets are enveloped by carrier fluid entering and exiting the bridge 17 via a protective film of the carrier fluid firm around the sample droplets. This provides a non-contacting solid surface that prevents carryover contamination from one sample droplet to the next sample droplet. The carrier fluid is used as the control fluid and is density-matched with the sample plugs such that a neutrally buoyant environment is created within the chamber. When two unmixed sample droplets arrive at the chamber in series from the inlet 18, the first droplet assumes a stable capillary-suspended spherical form upon entering the chamber (FIG. 3, panel A). The spherical shape grows until large enough to span the gap between the ports, forming an axisymmetric liquid bridge (FIG. 3, panel B). The second outlet 20 removes a flow of carrier fluid, e.g., oil, from the chamber causing the first sample droplet to slow and remain as a spherical shape at the first outlet 19. This allows time for a
second sample droplet to form a stable capillary-suspended spherical shape on entering the chamber 21. With the first sample droplet formed as a spherical shape at the outlet 19, and the second droplet formed as a spherical shape at the inlet 18, the first and second sample droplets can form as one and create an axisymmetric liquid bridge (FIG. 3, panel C). The mixed droplet then exits through the outlet port 19 (FIG. 3, panel D).
In certain embodiments, the flow conditions should be adjusted such that flow through the inlet 18 is greater than the flow through the second outlet 20. A typical flow through the inlet port 18 is about 5 μl/min, and can generally range from about 2 μl/min to about 7 μl/min. The flow away from the chamber 21 through the second outlet 20 is typically 2.5 μl/min and can generally range from about 1 μl/min to about 5 μl/min. Since there is conservation of mass flow within the bridge, this means that the flow through the first outlet 19 will balance the bridge to give a flow of typically 2.5 μl/min, and can generally range from about 1 μl/min to about 5 μl/min.
In certain embodiments, the liquid bridge 17 can be used with a constant outlet flow rate through the second outlet 20. In this embodiment, droplets can be mixed and the fluid flow through the system can be decreased. In addition, liquid bridge 17 can be used in conjunction with a sensor to time the withdrawal of fluid through the second outlet 20 so as to maintain a generally constant sample flow rate.
The sensor used can be a droplet detection sensor that includes a LED and photodiode. The LED is projected directly onto the center of the tube. A photodiode is positioned directly opposite the LED to pick up the light refracted through the rube. As a sample droplet having varying properties compared to that of the carrier fluid, e.g., oil, flows past the LED and photodiode, the light refracted through the liquid is altered slightly. This slight alteration is detected by the photodiode in the form of a change in voltage. This change in voltage can be used to time the control flow through second outlet port 20.
Liquid bridge systems of the invention can further include at least one robotics system to control the gas-free sampling devices. The robotics systems control movement of the sampling device between wells of the first and second arrays and also control sample acquisition. At least one pump is connected to the sampling device. An exemplary pump is shown in Davies et al. (WO 2007/091229, the contents of which are incorporated by reference herein in their entirety). Other commercially available pumps can also be used. The pumps are controlled by a flow
controller, e.g., a PC running WinPumpControl software (Open Cage Software, Inc., Huntington, NY), for control of direction of flow and flow rates.
Liquid bridge systems can be fluidly connected, e.g., tubes or channels, to an type of analysis device. In certain embodiments, the liquid bridge system is connected to a thermocycler to perform PCR reactions on the acquired sample. An exemplary thermocycler and methods of fluidly connecting a thermocycler to a liquid bridge system are shown in Davies et al. (WO 2005/023427, WO 2007/091230, and WO 2008/038259, the contents of each of which is incorporated by reference herein in its entirety). The thermocycler can be connected to an optical detecting device to detect the products of the PCR reaction. An optical detecting device and methods for connecting the device to the thermocycler are shown in Davies et al. (WO 2007/091230 and WO 2008/038259, the contents of each of which is incorporated by reference herein in its entirety).
In certain embodiments, the system is configured to perform single molecule detection, including digital PCR. Liquid bridge systems of the invention are useful in application in which one desires to detect and/or analyze a small number of analytes, down to the single molecule level. For example, the invention is useful for the detection of a desired analyte (e.g., a protein, a nucleic acid, a carbohydrate, or other biomarkers) in a heterogeneous sample. One important application of single molecule detection is digital nucleic acid amplification. Digital amplification and digital PCR are shown in Davies et al. (WO 2007/091230). Digital amplification is the process in which one amplifies a single nucleic acid template in order to generate a clonal population of amplicons. Digital amplification is useful to identify template molecules in samples, such as complex heterogeneous samples (e.g., urine, sputum, stool, puss, blood, or other bodily fluids); or to monitor a PCR reaction.
Digital PCR uses use fluorescent probes to monitor the amplification process as it progresses. SYBR Green 1 dye is an exemplary dye used for fluorescent detection of double stranded DNA generated during PCR. Through the analysis of the cycle-to-cycle change in fluorescence signal important information regarding the DNA sample is obtained. This is accomplished by illuminating the sample and detecting the resulting fluorescence. Different product concentration will demonstrate fluorescence amplification at difference cycle numbers. Through the analysis of the behavior of the sample the characterization is possible. An exemplary system for digital PCR is disclosed in Davies et al. (WO 2007/091230).
Methods of the invention further include analyzing the mixed droplet to detect a desired trait of the agricultural sample. The desired trait to be detected can be a biochemical trait, a marker, or a genotype. Exemplary biochemical traits include oil content, protein content, carbohydrate content, starch content, fiber content, water content, amino acid content, fatty acid content, nitrogen content, chlorophyll fluorescence, metabolites, oil composition, protein composition, carbohydrate composition, and fiber composition.
In other embodiments, the desired trait is linked to a genetic marker. In these embodiments, the desired trait is detected by extracting DNA from the agricultural samples, and screening the DNA for the presence or absence of the genetic marker. A wide variety of genetic markers are available and known to those of skill in the art. The screening may be used to select for quantitative trait loci (QTL), alleles, or genomic regions (haplotypes).
In one embodiment, the desired trait is linked to the presence or absence of a genetic marker that is genetically linked with a QTL. Examples of QTLs which are often of interest include but are not limited to yield, lodging resistance, height, maturity, disease resistance, pest resistance, resistance to nutrient deficiency, and grain composition. Alternatively, the desired trait is linked to the presence or absence of a marker that is genetically linked with a haplotype associated with a QTL. Examples of such QTL may again include without limitation yield, lodging resistance, height, maturity, disease resistance, pest resistance, resistance to nutrient deficiency, and grain composition.
Included within selectable or screenable marker genes are also genes that encode a secretable marker whose secretion can be detected as a method of identifying or selecting for transformed cells in an agricultural sample. Examples include markers that encode a secreted antigen that can be identified by antibody interaction, or even secreted enzymes that can be detected catalytically. Secreted proteins fall into a number of classes, including small, diffusible proteins detectable, e.g., by ELISA, small active enzymes detectable in extracellular solution (e.g., _-amylase, _-lactamase, phosphinothricin transferase), or proteins that are inserted or trapped in the cell wall (such as proteins which include a leader sequence such as that found in the expression unit of extension or tobacco PR-S). Other possible selectable and/or screenable marker genes will be apparent to those of skill in the art.
A variety of agents are useful in analyzing and detecting analytes in the sample (e.g., a desired trait). Such agents include, for example, polynucleotides, polypeptides, small molecules,
and/or antibodies useful in in situ screening assays for detecting the desired trait. An agent can be detectably labeled such that the agent is detectable when bound or hybridized to its target biomarker or ligand. Detectably labeling any of the foregoing agents includes an enzymatic, fluorescent, or radionucleotide label. Other reporter methods and labels are well known in the art.
An agent useful in the methods of the invention can be an antibody. The term "antibody" as referred to herein includes whole antibodies and any antigen binding fragment (i.e., "antigen binding portion") or single chains of these. A naturally occurring "antibody" is a glycoprotein including at least two heavy (H) chains and two light (L) chains inter-connected by disulfide bonds.
Antibodies useful in the methods of the invention include intact polyclonal or monoclonal antibodies, as well as fragments thereof, such as Fab and F(ab')2. For example, monoclonal antibodies are made from antigen containing fragments of a protein by methods well known to those skilled in the art (Kohler, et al., Nature, 256:495, 1975; and Harlow et al., Antibodies, Cold Spring Harbor Laboratory, pp. 93-117, 1988). Fluorescent molecules may be bound to an immunoglobulin either directly or indirectly by using an intermediate functional group.
An agent useful in the methods of the invention can also be a nucleic acid molecule (e.g., an oligonucleotide or polynucleotide probe). For example, in situ nucleic acid hybridization techniques are well known in the art and can be used to identify a RNA or DNA biomarker present in an agricultural sample. Screening procedures that rely on nucleic acid hybridization make it possible to identify a biomarker from any sample, provided the appropriate oligonucleotide or polynucleotide agent is available. For example, oligonucleotide agents, which can correspond to a part of a sequence encoding a target polypeptide, can be synthesized chemically or designed through molecular biology techniques. See Sambrook, et al., Molecular Cloning - A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. (1985). The polynucleotide encoding the target polypeptide can be deduced from the genetic code, however, the degeneracy of the code must be taken into account. For such screening, hybridization is typically performed under in situ conditions known to those skilled in the art. A number of fluorescent labels are known in the art and include DAPI, Cy3, Cy3.5, Cy5, CyS.5, Cy7, umbelliferone, fluorescein, fluorescein isothiocyanate (FITC), rhodamine, dichlorotriazinylamine fluorescein, dansyl chloride or phycoerythrin. A fluorescent label should
have distinguishable excitation and emission spectra. Where two or more fluorescent labels are used, they should have differing excitation and emission spectra that differ, respectively, by some minimal value (typically about 15-30 nm). The degree of difference will typically be determined by the types of filters being used in the process. Typical excitation and emission spectra for DAPI, FITC, Cy3, Cy3.5, Cy5, CyS.5, and Cy7 are provided below in table 1.
Table 1
D.A Pl
FITC 520 Cy3 550 Cy 3.5 Cy5 Cy5.5 6 SO
In other embodiments, the reagents are PCR reagents. A typical Q-PCR reaction contains: fluorescent double- stranded binding dye, Taq polymerase, deoxynucleotides of type A, C, G, and T, magnesium chloride, forward and reverse primers and cDNA, all suspended within an aqueous buffer. Reactants, however, may be assigned into two broad groups: universal and reaction specific. Universal reactants are those common to every Q-PCR reaction, and include: fluorescent double- stranded binding dye, Taq polymerase, deoxynucleotides A, C, G and T, and magnesium chloride. Reaction specific reactants include the forward and reverse primers and patient cDNA.
Oligonucleotide primers refer to linear, single- stranded, oligomeric deoxyribonucleic or ribonucleic acid molecules capable of sequence-specific hybridization (annealing) with complementary strands of modified or unmodified nucleic acid. In certain embodiments, the specific primers are DNA. The primers of the invention embrace oligonucleotides of appropriate sequence and sufficient length so as to provide for specific and efficient initiation of polymerization (primer extension) during the amplification process. As used in the inventive processes, oligonucleotide primers typically contain 12-30 nucleotides or more, although may contain fewer nucleotides. The exact length will depend on multiple factors including temperature (during amplification), buffer, and nucleotide composition. In certain embodiments,
primers are single-stranded although double- stranded primers may be used if the strands are first separated. Primers may be prepared using any suitable method, such as conventional phosphotriester and phosphodiester methods or automated embodiments which are commonly known in the art. The specific primers may be designed to be substantially complementary to each strand of the genomic locus of interest. Typically, one primer is complementary to the negative (-) strand of the locus (the "lower" strand of a horizontally situated double- stranded DNA molecule) and the other is complementary to the positve (+) strand ("upper" strand). Analytical methods of the invention allow individual seeds to be analyzed that are present in a batch or a bulk population of seeds such that the chemical and/or genetic traits of the individual seeds can be determined. Exemplary traits include starch content, protein content, oil content, determination of fatty acid profiles, etc.
Methods of the present invention can also be used in a breeding program to select plants or seeds having a desired trait or marker genotype. The methods of the present invention can be used in combination with any breeding methodology and can be used to select a single generation or to select multiple generations. DNA is obtained from the seed and analyzed for the presence or absence of at least one genetic marker. Based on the results of the DNA screening, seeds can be selected from the population, and plants can be cultivated from the selected seed. The choice of breeding method depends on the mode of plant reproduction, the heritability of the trait(s) being improved, and the type of cultivar used commercially (e.g., Fl hybrid cultivar, pureline cultivar, etc). Exemplary traits that can be detected include emergence vigor, vegetative vigor, stress tolerance, disease resistance, branching, flowering, seed set, seed size, seed density, standability, and threshability etc. In a particular embodiment, the methods of the present invention are used to determine the genetic characteristics of seeds in a marker-assisted breeding program.
Methods of the invention may also be used for introgressing a trait into a plant by removing DNA from an agricultural sample, screening the DNA extracted from the sample for the presence or absence of at least one genetic marker, selecting seeds from the population based upon the results of the DNA screening, cultivating a fertile plant from the seed, and utilizing the fertile plant as either a female parent or male parent in a cross with another plant. Examples of genetic screening to select seeds for trait integration include, without limitation, identification of high recurrent parent allele frequencies, tracking of transgenes of interest or screening for the
absence of unwanted transgenes, selection of hybrid testing seed, and zygosity testing. The identification of high recurrent pair allele frequencies via the screening methods of the present invention again allows for a reduced number of rows per population and an increased number of populations, or inbred lines, to be planted in a given field unit. Thus, the screening methods of the present invention may also effectively reduce the resources required to complete the conversion of inbred lines. The methods of the present invention further provide quality assurance and quality control by assuring that regulated or unwanted transgenes are identified and discarded prior to planting.
The methods of the present invention may be further applied to identify hybrid seeds for transgene testing. For example, in a conversion of an inbred line at the BCnFl stage, a breeder could effectively create a hybrid seed lot (barring gamete selection) that was 50% hemizygous for the trait of interest and 50% homozygous for the lack of the trait in order to generate hybrid seeds for testing. The breeder could then screen all Fl seeds produced in the test cross and identify and select those seeds that were hemizygous. Such a method is advantageous in that inferences from the hybrid trials would represent commercial hybrid genetics with regard to trait zygosity.
In certain embodiments, methods of the invention are used to determine ploidy of an organism. Ploidy refers to the number of complete sets of chromosomes in an organism, such as a plant. Plants can be, for example, haploid, diploid, triploid, tetraploid, polyploid, or aneuploid. Also, ploidy of cells can vary within an organism.
Still further, screening methods of the invention are used to improve the efficiency of a doubled haploid program. In agriculture, a doubled haploid is an organism having two identical sets of chromosomes. Double haploids are produced from haploid pollen or egg cells that are induced to undergo chromosome doubling. Haploid cells occur naturally in the gametophytic phases of higher plants in their ovules and pollen. By manipulating the gametic cells, it is possible to produce homozygous embryos rather than mature pollen grains or ovules. By induced or spontaneous chromosome doubling, a completely homozygous doubled haploid plant can be produced. Conventional inbreeding procedures take about six generations to achieve completely homozygous genomes, whereas double haploidy reduces the breeding process to essentially one step. Using methods of the invention described above, one improve the efficiency of a doubled haploid program through selection of desired genotypes at the haploid stage and identification of
ploidy level to eliminate non-haploid seeds from being processed and advancing to the field. In another embodiment, the invention further provides an assay for predicting embryo zygosity for a particular gene of interest. The assay predicts embryo zygosity based on the ratio of the relative copy numbers of a selected gene and an internal control gene per cell or per genome. Generally, this assay uses a control gene that is of known zygosity, for normalizing measurement of the selected gene. The ratio of the relative copy numbers of the control to the selected gene predicts the gene copy number in the cell. In a homozygous cell, for any given gene (or unique genetic sequence), the gene copy number is equal to the ploidy of the cell since the sequence is present at the same locus in all homologous chromosomes. When a cell is heterozygous for a particular gene, the gene copy number will be lower than the ploidy level of the cell. The zygosity of a cell at any locus can thus be determined by the gene copy number in the cell.
The invention having now been described, it is further illustrated by the following examples and claims, which are illustrative and are not meant to be further limiting. Those skilled in the art will recognize or be able to ascertain using no more than routine experimentation, numerous equivalents to the specific procedures described herein. Such equivalents are within the scope of the present invention and claims.
The contents of all references and citations, including issued patents, published patent applications, and journal articles cited throughout this application, are hereby incorporated by reference in their entireties for all purposes.
Examples
Example 1 : Rupturing of a sample in a liquid bridge
Liquid bridge stability was studied as a means to predicting the geometric conditions at which rupture occurs. Liquid bridge rupture may be defined as the complete breakage of the liquid filament connecting one solid support to the other. The dimensionless parameters characterizing liquid bridges are used to define the stability boundary at which rupture was observed. FIG. 4 presents images of liquid bridges at three slenderness conditions just prior to rupture. The rupture was caused by the withdrawal of liquid bridge fluid from one capillary tube. It was observed that low slenderness ratio liquid bridges, an example of which is shown in FIG.
4, panel A, adopt a thimble shape at the minimum volume stability. Larger slenderness ratio liquid bridges, such as that shown in FIG. 4, panel C, possess a barrel form with a maximum radius at the bridge mid-span. Intermediate slenderness ratios were found to have a near cylindrical shape at the minimum volume stability limit. FIG. 4, panels A-C show liquid bridges with slenderness ratios of 1.09, 2.45 and 6.16 respectively.
Example 2: Stability of a liquid bridge with respect to slenderness and volume
The stability of liquid bridges was examined as a function of slenderness, Λ*, which is the ratio of tip separation, L , to the mean diameter, 2Ro , of the supporting capillaries, i.e. Λ* = L/2Ro . Stability was also investigated as a function of volumetric ratio, V*, which is the ratio of liquid bridge volume to the volume of a cylinder with a radius R0 , the average radius of the supporting capillaries, i.e.:
The location of the stability boundary, or rupture point, was determined experimentally by fixing the slenderness, establishing a stable liquid bridge between capillary tips and withdrawing fluid from one capillary until rupture was observed. A digital image of the liquid bridge just prior to rupture was then analyzed, using an edge detection measurement technique to determine the total volume and hence the volumetric ratio, V*. The slenderness was then adjusted and the experiment repeated. K* represents the ratio of the radius of the smaller disk, R1, to the radius of the larger one, R2 , that is K* = R1/ R2 . FIG. 7 shows the approximate location of the minimum volume stability boundary for liquid bridges with a lateral Bond number of 1.25 x 10~4, a near weightless environment. Vertical and horizontal error bars indicate experimental uncertainty.
At high volumetric ratios, FIG. 4 panel C for example, bridges maintain their integrity and reach a minimum energy configuration. At low volumetric ratios, FIG. 4 panel A for example, the bridges break before the interfacial energy is minimized. The initial dip in the stability boundary at low slenderness ratios was caused by low-volume droplets not fully wetting the exposed fused silica of the capillary tips. The influence of unequal capillaries on the Λ*- V* stability diagram is also shown in FIG. 5. It can be seen that the unstable region of the Λ* - V* plane increases as the parameter K*, the ratio of capillary radii, decreases. The results presented in FIG. 5 confirmed that the static stability of liquid bridge is purely geometrical at low Bond
numbers. It is notable that low slenderness ratio bridges are almost completely stable, with respect to rupture, for all capillary radii measured.
Rupture was observed only at very low volumetric ratios with the liquid bridge assuming a thimble shape. Liquid bridge instability when applied to fluid dispensing is particularly useful as a replacement for micro-channel shear-based dispensing systems. In more detail, FIG. 5 shows a stability diagram for a de-ionized water liquid bridge in a density matched silicone oil, Bond number: 1.25 x 10~4. Vertical error bars indicate the volumetric ratio uncertainty as a result of camera frame rate. Horizontal error bars indicate slenderness uncertainty due to capillary tip misalignment. The parameter K* is the ratio of supporting capillary radii.
Example 3: Dispensing sub-microliter volumes
The following describes the use of liquid bridge instability as a mechanism for dispensing sub-microliter volumes of fluid in a continuous manner. The dispensing mechanism provided a reliable means of producing uniform aqueous plugs separated by silicone oil that did not rely on the shear force exerted by the carrier fluid. The repeatability with which the method dispensed plugs was examined. The approach used the liquid bridge's dependence on geometry to create a periodic instability between opposing capillary tips. A stable liquid bridge was first established between aqueous inlet and outlet. The volume held in this bridge was then steadily reduced by the action of the silicone oil inlet. This caused the formation of an unstable liquid bridge that ruptured to release a smaller plug at the outlet. The segmenting mechanism provided a reliable means of producing uniform aqueous plugs separated by silicone oil that did not rely on the shear force exerted by the carrier fluid. Furthermore, a protective oil film was established between the walls of the circular capillaries and the droplet to prevent carryover contamination.
FIG. 6 panels A-D shows images of a liquid bridge dispensing at four different slenderness ratios. (A) A* = 0, (B) A* = 0.76, (C) A* = 1.37 and (D) A* = 2.31. Q* = 0.5, K* = 0.44. Increasing the capillary tip separation, and hence the slenderness ratio increased the plug volumes dispensed. Q* , the oil flow rate as a fraction of the total flow rate, was maintained constant at 0.5. FIG. 6 panel A shows dispensing with the dispensing capillary inserted inside the outlet capillary. This configuration was assigned a slenderness ratio, A* of zero. Slenderness ratios close to zero resulted in the smallest volume plugs dispensed for this geometry. The effect of increasing tip separation on dispensed plug volume is shown in FIG. 6 panels B-D. Increasing
tip separation, i.e. slenderness ratio, resulted in larger volume aqueous plugs punctuated by approximately the same volume of silicone oil. This was due to the silicone oil inlet flow rate being maintained constant and equal to the aqueous droplet inlet flow rate.
FIG. 7 presents a plot of V*, against slenderness ratio, Λ* , where V* is the dimensionless plug volume scaled with RQ3 , i.e.:
V* = V /Rn
Results are presented for three different values of the oil flow rate fraction, Q*, with the ratio of capillary tip radii, K*, maintained constant at 0.44. The axis on the right-hand side of the plot indicates the measured plug volume. Horizontal error bars indicate slenderness uncertainty as a result of positional inaccuracy. Vertical error bar are a result of uncertainty in the plug volume calculation due to image processing. The results show the expected trend of increased plug volume with liquid bridge slenderness ratio. Decreasing Q* resulted in a dramatic increase in dimensionless plug volume. Altering Q* also affected the volume of silicone oil separating the aqueous plugs as Q * is the oil flow rate as a fraction of the total flow rate. The lowest repeatable volume measured using this particular geometry was approximately 90 nL with Λ* = 0, Q* = 0.75. The highest volume measured was approximately 3.9 μL with Λ* = 2.36 , Q* = 0.25 .
In flows where the non- wetting fluid, i.e. the aqueous phase, was displaced by wetting fluid, i.e. oil, a thin film of the wetting fluid separated the droplets from the capillary surface. The thickness of the film resulted from a balance between the oil viscosity, η , and the interfacial tension, d. The thickness of the oil film deposited in a capillary of radius r is given by;
h = 1.34r(Ca2/3). (Equation (0.1)
The capillary number, Ca , is given by:
Ca = ηU/σ, , (Equation (0.2)
where U represents the mean velocity of the flow. Equation (0.1) is obeyed if the film is thin enough to neglect geometric forces, h < 0. Ir , and thick enough to avoid the influence of long
range molecular attraction, h>100 nm. Typical oil film thicknesses for plug flow through 400 μm polymeric fluorocarbon internal diameter tubing were calculated to be of the order of 1 μm.
This film thickness was too small to resolve with any degree of accuracy from experimental images. However, the oil film did form a protective coating preventing aqueous reactor fluid from contacting the Teflon tubing. This had the advantage of preventing a mechanism responsible for carryover contamination whereby small droplets may be deposited onto the walls of micro-channels. Table 2 below presents two examples of oil- surfactant combinations that were used to successfully establish protective oil films around flowing droplets. Surfactant additives acted to change the interfacial tension between droplets and the oil carrier fluid such as to promote the establishment of a protective oil film, the thickness of which is given by Equation 0.1.
Table 2
FIG. 8 presents a dimensionless plot of the product of V* and Q* versus Λ*. The data, taken from the plot shown in FIG. 7, collapsed on to the trend line within the bounds of uncertainty. The data applied to geometries with K* = 0.44. Notwithstanding this geometric constraint, the collapsed data did yield valuable design information.
Consider a microfiuidic system designer deciding on an appropriate geometry for a segmenting device. The designer will usually know the exact volume to dispense from the outline specification for the device. If there is a sample frequency requirement, the designer may also know a value for Q*. Recalling that K* = R1 /R2 , where R1 and R2 are the inlet and outlet diameters respectively makes the design process relatively easy. Deciding on an arbitrary value for an outlet diameter fixes the aqueous inlet diameter as the data shown in FIG. 9 applies to only to geometries with K* = 0.44. With this information in hand, an appropriate value for
V*(Q*) may be calculated. The corresponding value for Λ* may then be read from the design curve shown in FIG. 8. Finally, Λ* was used to calculate the tip separation between the inlet and outlet.
Example 4: Droplet volume with respect to liquid bridges
The data presented in Figs. 7 and 8 applied to geometries with K* = 0.44. The effect of altering K* on plug volumes dispensed was also investigated. FIG. 10 panels A-C shows a liquid bridge dispensing at three different values for K*. Panels (A), (B) and (C) correspond to K* values of 0.25, 0.44 and 1.0 respectively. K* value of 0.25 was achieved by assembling a 200 μm fused silica microcapillary at the end of a polymeric capillary tube by a reduction of internal diameter through appropriately sized fused silica. Sealing was ensured with the addition of cyanoacrylate glue at the sleeve interfaces.
FIG. 9 presents a dimensionless plot of V* versus Λ* for three different values of K*. The dimensionless plug volume, V*, was scaled with R2 3 , and not Ro3 as previously. This permitted a direct comparison of dimensionless plug volumes as R2 remained constant throughout the experiment. It was observed that decreasing K* generally lowered the plug volumes dispensed for any given value of slenderness, Λ*. The minimum volume dispensed with K* = 0.25 was approximately 60 nL whilst that of K* = 0.44 and K* = 1 was approximately 110 nL. Attempts to collapse the data shown in FIG. 9 onto a single line, similar to the plot shown in FIG. 8, were unsuccessful. This was due to the highly non-linear relationship between K* and V* for any given value of Λ*.
Example 5: Repeatability of dispensing sub-microliter volumes
The repeatability with which the liquid bridge dispensing system could deliver fluid was of particular interest. FIG. 11 plots plug volume variation over fourteen measurements for a dispensing system with K* = 0.44. The results show mean plug volumes of approximately 120 nL and 56 nL with maximum volumetric variations of ±4.46% and ±3.53% respectively. These volumetric variations compared favorably to commercial available micropipettes that have an uncertainty of ±12% when dispensing 200 nL. The accuracy with which one may dispense using micropipettes, however, is thought to be largely dependant upon user skill. The automation of dispensing systems may therefore be justified as a means of eliminating user-user variability.
The volumetric analysis presented in FIG. 11 shows liquid bridge dispensing to be a very repeatable means of continuously dispensing sub-microliter volumes of fluid.
FIG. 12 is an image of a liquid bridge. The bridge consisted of two opposing capillaries of the same external diameter. The second inlet part was of a finer capillary orientated at right angles to and situated half-way between the other two capillaries. Constraints on opposing capillary radius and the placement of the third capillary helped to simplify the dimensionless stability study. The investigation also necessitated modifications to the dimensionless parameters characterizing axisymmetric liquid bridge geometry. The slenderness ratio, Λ* , was calculated using:
2 R X,i Equation (1) where L and S correspond to the distances indicated in FIG. 12. R0 is defined as the mean radius, i.e. (R1 +R2) /2. K* is defined as R1ZR2 . The volumetric ratio, V*, is defined as:
where ^ is the measured volume at which bridge collapse occurs. In terms of the geometry presented in FIG. 12, a funicular bridge collapse corresponded to detachment from the finer capillary.
FIG. 13 shows a stability diagram for the approximate location of the minimum volume stability boundary for purified water funicular liquid bridges with a lateral Bond number of 1.25 x 10~4, a near weightless environment. The boundaries of stability were found by fixing a value for Λ*, establishing a stable funicular bridge and withdrawing fluid until the bridge collapsed. The collapse was recorded via a CCD and the frame immediately following rupture was analyzed to measure the volume. The calculation of the bridge volume was simplified by the fact that the collapsed funicular bridge exhibited axisymmetry with respect to the axis of the two larger capillaries. Minimum volume stability boundaries were plotted for K* = 0.25 and K* = 0.44. Lower K * values displayed increased instability. Volumetric data for Λ* values lower than
approximately 1.5 were difficult to obtain with the geometry used and so were omitted from the stability diagram.
The formation of a funicular bridge deemed unstable by the graph shown in FIG. 13 ensured the injection of fluid into an aqueous plug passing through opposing capillaries. A further advantage to using funicular bridge dispensers is based on the speed at which the process takes place. Typical instabilities last of the order of 100 ms, insufficient time for the host droplet fluid to diffuse to the dispensing capillary tip. This is a further preventative measure against carryover contamination.
The two input one output, funicular bridge can be configured so that the expression profile of many genes may be addressed. One input contains the primer and premix in a continuous phase, the outlet then delivers them in droplet form. Firstly many input and output capillaries, say p , can be set in planes perpendicular to that of FIG. 1. A perpendicular arrangement allows for good optical access in the planar thermocycler which is connected to the output. Each arrangement of two inputs and one output can be used to address a single primer, giving p primers. This, however, would make for a very long device in the plane perpendicular to FIG. 1. If serially variant primers were fed into each input, numbering q , this would reduce the scale. Further, if the primers were multiplexed, to order r , in each droplet the scale would be further reduced. The number of primers that could then be addressed would be: N = p x q x r. By this means, a PCR test of the whole genome of any living form, including the human, could be addressed, which would have applications beyond diagnosis, in many fields of pure and applied science.
Claims
1. A method for analyzing an agricultural sample, the method comprising the steps of: mixing an agricultural sample in a first fluid; providing a liquid bridge for mixing an analyte in the sample with at least one reagent to form a mixed droplet that is wrapped in an immiscible second fluid; and analyzing the mixed droplet to detect a trait of the agricultural sample.
2. The method according to claim 1, wherein the immiscible second fluid is oil.
3. The method according to claim 1, wherein the agricultural sample is selected from the group consisting of: a seed, a batch of seeds, a portion of a seed, or a seed scraping.
4. The method according to claim 1, wherein the agricultural sample comprises plant tissue.
5. The method according to claim 4, wherein the plant tissue is selected from the group consisting of: a leaf, a leaf punch, a flower, a root, and a petal.
6. The method according to claim 1, wherein the agricultural sample comprises non-plant based material.
7. The method according to claim 5, wherein the non-plant based material comprises a fungal sample.
8. The method according to claim 1, wherein the desired trait is a biochemical trait.
9. The method according to claim 8, wherein the biochemical trait is selected from the group consisting of: oil content, protein content, carbohydrate content, starch content, fiber content, water content, amino acid content, fatty acid content, nitrogen content, chlorophyll fluorescence, metabolites, oil composition, protein composition, carbohydrate composition, and fiber composition.
10. The method according to claim 1, wherein the desired trait is linked to a genetic marker.
11. The method according to claim 1, wherein the reagent is a labeled antibody specific for a gene or gene product of the agricultural sample.
12. The method according to claim 1, wherein the reagent is a labeled DNA probe or a labeled RNA probe.
13. The method according to claim 1, further comprising performing PCR on the gene in the mixed droplet.
14. The method according to claim 13, wherein the reagents comprise primers and polymerases.
15. A method for determining presence of a desired trait in a progeny agricultural sample comprising: obtaining a nucleic acid from a progeny agricultural sample, wherein the nucleic acid is in a first fluid; providing a liquid bridge for mixing the nucleic acid with at least one reagent to form a mixed droplet that is wrapped in an immiscible second fluid; performing PCR on the nucleic acid in the mixed droplet; and analyzing the nucleic acid in the mixed droplet to determine presence of the desired trait in the progeny agricultural sample.
16. The method according to claim 15, wherein the immiscible second fluid is oil.
17. The method according to claim 15, wherein the agricultural sample is selected from the group consisting of: a seed, a batch of seeds, a portion of a seed, or a seed scraping.
18. The method according to claim 15, wherein the agricultural sample comprises plant tissue.
19. The method according to claim 18, wherein the plant tissue is selected from the group consisting of: a leaf, a leaf punch, a flower, a root, and a petal.
20. The method according to claim 15, wherein the desired trait is a genetically inheritable trait.
21. The method according to claim 20, wherein the genetically inheritable trait is selected from the group consisting of: pod color, flower color, seed yield, pubescence color, and herbicide resistance.
22. The method according to claim 15, wherein the reagents comprise primers and polymerases.
23. A method for analyzing an environmental sample for presence of a biological agent comprising: providing a liquid bridge for mixing an aliquot of an environmental sample in a first fluid with at least one reagent to form a mixed droplet that is wrapped in an immiscible second fluid; and analyzing the mixed droplet to detect presence or absence of a biological agent in the environmental sample.
24. The method according to claim 23, wherein the immiscible second fluid is oil.
25. The method according to claim 23, wherein the biological agent is selected from the group consisting of: a toxin, an allergen, a metabolite, a bacteria, a yeast, a mold, and a fungus.
26. The method according to claim 23, wherein the environmental sample is a soil sample or a water sample.
27. The method according to claim 23, wherein the reagent is a labeled antibody specific for the biological agent in the environmental sample.
28. The method according to claim 23, wherein the reagent is a labeled DNA probe or a labeled RNA probe.
29. The method according to claim 23, wherein prior to the providing step, the method further comprises obtaining a gene or gene product from the biological agent in the environmental sample.
30. The method according to claim 29, wherein the reagent is a labeled antibody specific for the gene or gene product from the biological agent in the environmental sample.
31. The method according to claim 29, wherein the reagent is a labeled DNA probe or a labeled RNA probe that binds to the gene or gene product from the biological agent in the environmental sample.
32. The method according to claim 29, wherein prior to the analyzing step, the method further comprises performing PCR on the gene from the biological agent in the mixed droplet.
33. The method according to claim 32, wherein the reagents comprise primers and polymerases.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10742240A EP2433126A1 (en) | 2009-05-20 | 2010-05-10 | Methods for analyzing agricultural and environmental samples using microfluidic systems |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/469,339 US8735169B2 (en) | 2006-02-07 | 2009-05-20 | Methods for analyzing agricultural and environmental samples |
US12/469,339 | 2009-05-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2010133962A1 true WO2010133962A1 (en) | 2010-11-25 |
Family
ID=42931983
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2010/001233 WO2010133962A1 (en) | 2009-05-20 | 2010-05-10 | Methods for analyzing agricultural and environmental samples using microfluidic systems |
Country Status (3)
Country | Link |
---|---|
US (1) | US8735169B2 (en) |
EP (1) | EP2433126A1 (en) |
WO (1) | WO2010133962A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8298833B2 (en) | 2006-02-07 | 2012-10-30 | Stokes Bio Limited | Liquid bridge and system |
US8501497B2 (en) | 2006-02-07 | 2013-08-06 | Stokes Bio Limited | Forming sample combinations using liquid bridge systems |
US10676786B2 (en) | 2003-09-05 | 2020-06-09 | Stokes Bio Ltd. | Microfluidic analysis system |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9562837B2 (en) | 2006-05-11 | 2017-02-07 | Raindance Technologies, Inc. | Systems for handling microfludic droplets |
US20080014589A1 (en) | 2006-05-11 | 2008-01-17 | Link Darren R | Microfluidic devices and methods of use thereof |
US8772046B2 (en) | 2007-02-06 | 2014-07-08 | Brandeis University | Manipulation of fluids and reactions in microfluidic systems |
WO2010009365A1 (en) | 2008-07-18 | 2010-01-21 | Raindance Technologies, Inc. | Droplet libraries |
US12038438B2 (en) | 2008-07-18 | 2024-07-16 | Bio-Rad Laboratories, Inc. | Enzyme quantification |
US9364803B2 (en) * | 2011-02-11 | 2016-06-14 | Raindance Technologies, Inc. | Methods for forming mixed droplets |
EP3736281A1 (en) | 2011-02-18 | 2020-11-11 | Bio-Rad Laboratories, Inc. | Compositions and methods for molecular labeling |
EP2694213B1 (en) | 2011-04-08 | 2020-05-06 | Stokes Bio Limited | Biological detection system |
EP2714970B1 (en) | 2011-06-02 | 2017-04-19 | Raindance Technologies, Inc. | Enzyme quantification |
US8658430B2 (en) | 2011-07-20 | 2014-02-25 | Raindance Technologies, Inc. | Manipulating droplet size |
DE102012109317A1 (en) * | 2012-10-01 | 2014-04-03 | Astrium Gmbh | Device for carrying out a biochemical analysis, in particular in space |
FR3046461A1 (en) * | 2016-01-04 | 2017-07-07 | Teclis | SYSTEM AND METHOD FOR ANALYZING THE INTERACTION BETWEEN A FLUID DROP AND ANOTHER DROP OR SOLID SURFACE |
Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6107549A (en) | 1998-03-10 | 2000-08-22 | Monsanto Company | Genetically engineered plant resistance to thiazopyr and other pyridine herbicides |
US6255560B1 (en) | 1983-01-17 | 2001-07-03 | Monsanto Company | Chimeric genes for transforming plant cells using viral promoters |
US6603061B1 (en) | 1999-07-29 | 2003-08-05 | Monsanto Company | Agrobacterium-mediated plant transformation method |
US6646264B1 (en) | 2000-10-30 | 2003-11-11 | Monsanto Technology Llc | Methods and devices for analyzing agricultural products |
WO2005023427A1 (en) | 2003-09-05 | 2005-03-17 | Stokes Bio Limited | A microfluidic analysis system |
US7208654B2 (en) | 2003-05-07 | 2007-04-24 | Monsanto Technology Llc | Plant regulatory sequences for selective control of gene expression |
WO2007091230A1 (en) | 2006-02-07 | 2007-08-16 | Stokes Bio Limited | A microfluidic analysis system |
WO2007091229A1 (en) | 2006-02-07 | 2007-08-16 | Stokes Bio Limited | A microfluidic droplet queuing network |
WO2007091228A1 (en) | 2006-02-07 | 2007-08-16 | Stokes Bio Limited | A liquid bridge and system |
US20070240242A1 (en) | 2006-04-06 | 2007-10-11 | Monsanto Technology Llc | Method for multivariate analysis in predicting a trait of interest |
WO2008038259A1 (en) | 2006-09-28 | 2008-04-03 | Stokes Bio Limited | A qpcr analysis apparatus |
US7367155B2 (en) | 2000-12-20 | 2008-05-06 | Monsanto Technology Llc | Apparatus and methods for analyzing and improving agricultural products |
US7502113B2 (en) | 2004-08-26 | 2009-03-10 | Monsanto Technology Llc | Automated seed sampler and methods of sampling, testing and bulking seeds |
US20090075325A1 (en) | 2007-09-19 | 2009-03-19 | Monsanto Technology Llc | Systems and methods for analyzing agricultural products |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6193471B1 (en) | 1999-06-30 | 2001-02-27 | Perseptive Biosystems, Inc. | Pneumatic control of formation and transport of small volume liquid samples |
GB0026404D0 (en) | 2000-10-28 | 2000-12-13 | Siddall & Hilton Ltd | Body support arrangements |
FR2839504B1 (en) * | 2002-05-07 | 2004-06-18 | Commissariat Energie Atomique | DEVICE AND METHOD FOR DISPENSING LIQUID PRODUCTS |
US7655470B2 (en) * | 2004-10-29 | 2010-02-02 | University Of Chicago | Method for manipulating a plurality of plugs and performing reactions therein in microfluidic systems |
US8501497B2 (en) | 2006-02-07 | 2013-08-06 | Stokes Bio Limited | Forming sample combinations using liquid bridge systems |
US8492168B2 (en) * | 2006-04-18 | 2013-07-23 | Advanced Liquid Logic Inc. | Droplet-based affinity assays |
-
2009
- 2009-05-20 US US12/469,339 patent/US8735169B2/en not_active Expired - Fee Related
-
2010
- 2010-05-10 WO PCT/IB2010/001233 patent/WO2010133962A1/en active Application Filing
- 2010-05-10 EP EP10742240A patent/EP2433126A1/en not_active Ceased
Patent Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6255560B1 (en) | 1983-01-17 | 2001-07-03 | Monsanto Company | Chimeric genes for transforming plant cells using viral promoters |
US6107549A (en) | 1998-03-10 | 2000-08-22 | Monsanto Company | Genetically engineered plant resistance to thiazopyr and other pyridine herbicides |
US6603061B1 (en) | 1999-07-29 | 2003-08-05 | Monsanto Company | Agrobacterium-mediated plant transformation method |
US6646264B1 (en) | 2000-10-30 | 2003-11-11 | Monsanto Technology Llc | Methods and devices for analyzing agricultural products |
US7367155B2 (en) | 2000-12-20 | 2008-05-06 | Monsanto Technology Llc | Apparatus and methods for analyzing and improving agricultural products |
US7208654B2 (en) | 2003-05-07 | 2007-04-24 | Monsanto Technology Llc | Plant regulatory sequences for selective control of gene expression |
WO2005023427A1 (en) | 2003-09-05 | 2005-03-17 | Stokes Bio Limited | A microfluidic analysis system |
US7502113B2 (en) | 2004-08-26 | 2009-03-10 | Monsanto Technology Llc | Automated seed sampler and methods of sampling, testing and bulking seeds |
WO2007091230A1 (en) | 2006-02-07 | 2007-08-16 | Stokes Bio Limited | A microfluidic analysis system |
WO2007091228A1 (en) | 2006-02-07 | 2007-08-16 | Stokes Bio Limited | A liquid bridge and system |
WO2007091229A1 (en) | 2006-02-07 | 2007-08-16 | Stokes Bio Limited | A microfluidic droplet queuing network |
US20070240242A1 (en) | 2006-04-06 | 2007-10-11 | Monsanto Technology Llc | Method for multivariate analysis in predicting a trait of interest |
WO2008038259A1 (en) | 2006-09-28 | 2008-04-03 | Stokes Bio Limited | A qpcr analysis apparatus |
US20090075325A1 (en) | 2007-09-19 | 2009-03-19 | Monsanto Technology Llc | Systems and methods for analyzing agricultural products |
Non-Patent Citations (3)
Title |
---|
KOHLER ET AL., NATURE, vol. 256, 1975, pages 495 |
SIFFERTA ET AL., MICROBES & INFECTION, 1999, pages 1159 - 1162 |
ZHAO ET AL., ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, pages 1522 - 1528 |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10676786B2 (en) | 2003-09-05 | 2020-06-09 | Stokes Bio Ltd. | Microfluidic analysis system |
US11807902B2 (en) | 2003-09-05 | 2023-11-07 | Stokes Bio Ltd. | Microfluidic analysis system |
US8298833B2 (en) | 2006-02-07 | 2012-10-30 | Stokes Bio Limited | Liquid bridge and system |
US8501497B2 (en) | 2006-02-07 | 2013-08-06 | Stokes Bio Limited | Forming sample combinations using liquid bridge systems |
US9533304B2 (en) | 2006-02-07 | 2017-01-03 | Stokes Bio Limited | Forming sample combinations using liquid bridge systems |
US10730051B2 (en) | 2006-02-07 | 2020-08-04 | Stokes Bio Ltd. | Liquid bridge and system |
US11772096B2 (en) | 2006-02-07 | 2023-10-03 | Stokes Bio Ltd. | System for processing biological sample |
Also Published As
Publication number | Publication date |
---|---|
EP2433126A1 (en) | 2012-03-28 |
US20100216128A1 (en) | 2010-08-26 |
US8735169B2 (en) | 2014-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8735169B2 (en) | Methods for analyzing agricultural and environmental samples | |
US7906318B2 (en) | Testing microreactor, testing device and testing method | |
EP1192007B1 (en) | Microchip matrix device for duplicating and characterizing nucleic acids | |
EP3031918B1 (en) | Microfluidic devices | |
US20180111118A1 (en) | Handling liquid samples | |
US11667970B2 (en) | Spatial molecular analysis of tissue | |
US20140208832A1 (en) | Methods and Apparatus for Flow-Controlled Wetting | |
CN108603224B (en) | High level multiplexed amplification | |
WO2013113889A1 (en) | Multiplexed digital pcr | |
EP3525933B1 (en) | Systems and methods to encapsulate and preserve organic matter for analysis | |
CN109564185A (en) | The score abundance of polynucleotide sequence in sample | |
EP1880766A1 (en) | Analysis system based on porous material for highly-parallel single cell detection | |
CN101348763B (en) | Apparatus for polynucleotide detection and quantitation | |
Rayner et al. | Genetic variation controlling wrinkled seed phenotypes in Pisum: how lucky was Mendel? | |
CN109486963A (en) | A kind of mankind KIR Genotyping detection primer group and application | |
Chen et al. | High‐throughput procedure for single pollen grain collection and polymerase chain reaction in plants | |
Liu et al. | Automated melting curve analysis in droplet microfluidics for single nucleotide polymorphisms (SNP) genotyping | |
EP3558525B1 (en) | Combined extraction and pcr systems | |
CN108291251A (en) | System and method for foranalysis of nucleic acids | |
Roberts et al. | A nanoliter fluidic platform for large-scale single nucleotide polymorphism genotyping | |
WO2020218554A1 (en) | Digital somatic cell variation analysis | |
CN112877460A (en) | Transgenic component high-throughput screening method, detection kit and application thereof | |
RU2386698C1 (en) | Method of identifying transgenic dna sequences in plant material and products based on plant material | |
CN117205980A (en) | Microfluidic chip and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10742240 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010742240 Country of ref document: EP |